{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":2397,"total_is_capped":false,"direct_labels_cover":1,"predictions_cover":2397,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"c0ea6a3cf2ea","filters":{"topic":"Multiple Myeloma Research and Treatments"}},"results":[{"id":"W2486629951","doi":"10.1016/s1470-2045(16)30206-6","title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","year":2016,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2995,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Multiple myeloma; Minimal residual disease; Medicine; Bone marrow; Myeloma protein; Clinical trial; Disease; Oncology; Monoclonal; Internal medicine; Monoclonal antibody; Immunology; Antibody","authors":[{"name":"Shaji Kumar","is_ca":false},{"name":"Bruno Paiva","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false},{"name":"Brian G.M. Durie","is_ca":false},{"name":"Ola Landgren","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Nikhil C. Munshi","is_ca":false},{"name":"Sagar Lonial","is_ca":false},{"name":"Joan Bladé","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Efstathios Kastritis","is_ca":false},{"name":"Mario Boccadoro","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Andrew Spencer","is_ca":false},{"name":"Jian Hou","is_ca":false},{"name":"Wee Joo Chng","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false},{"name":"Elena Zamagni","is_ca":false},{"name":"Kazuyuki Shimizu","is_ca":false},{"name":"Sundar Jagannath","is_ca":false},{"name":"Hans Erik Johnsen","is_ca":false},{"name":"Evangelos Terpos","is_ca":false},{"name":"Tony Reiman","is_ca":true},{"name":"Robert A. Kyle","is_ca":false},{"name":"Pieter Sonneveld","is_ca":false},{"name":"Paul G. Richardson","is_ca":false},{"name":"Philip L. McCarthy","is_ca":false},{"name":"Heinz Ludwig","is_ca":false},{"name":"Wen-Ming Chen","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Jean‐Luc Harousseau","is_ca":false},{"name":"Suzanne Lentzsch","is_ca":false},{"name":"Jens Hillengaß","is_ca":false},{"name":"Antonio Palumbo","is_ca":false},{"name":"Alberto Órfão","is_ca":false},{"name":"S. Vincent Rajkumar","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false},{"name":"Hervé Avet‐Loiseau","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1849845355372984,"gpt":0.4731506599377273,"spread":0.2881661244004289,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02035962,0.001671835,0.008345437,0.005463595,0.0008364171,0.003302782,0.004407658,0.002701049,0.003527327],"category_scores_gemma":[0.0311626,0.0007031651,0.006637072,0.003992476,0.001730304,0.001842911,0.002407068,0.004147543,0.001278413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004842759,"about_ca_system_score_gemma":0.01080067,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008423733,"about_ca_topic_score_gemma":0.01306157,"domain_scores_codex":[0.9893876,0.003857712,0.003528046,0.0004765324,0.002374928,0.0003751316],"domain_scores_gemma":[0.981818,0.01140189,0.00289162,0.0003034743,0.003216306,0.0003687209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001108975,0.000134728,0.004589734,0.1269219,0.003562734,0.0002381485,0.0004197025,0.00108509,0.0007080137,0.007693138,0.1016684,0.7518695],"study_design_scores_gemma":[0.002085608,0.0006830731,0.02539524,0.2171715,0.01410533,0.002368834,0.0006840591,0.001770611,0.001299681,0.01882618,0.715267,0.0003427727],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005837761,0.9829705,0.002838294,0.006184016,0.001356168,0.001054248,0.0009768977,0.00007742318,0.003958716],"genre_scores_gemma":[0.02745804,0.9124593,0.03521663,0.01091144,0.002228097,0.004419878,0.00461038,0.00007560513,0.002620622],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02035962,"threshold_uncertainty_score":0.1076732,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2101035019","doi":"10.1038/nature09837","title":"Initial genome sequencing and analysis of multiple myeloma","year":2011,"lang":"en","type":"article","venue":"Nature","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1439,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Multiple Myeloma Research Foundation; National Human Genome Research Institute; National Institute on Aging; Leukaemia and Lymphoma Research; Broad Institute","keywords":"Biology; Multiple myeloma; Gene; Genome; Genetics; Massive parallel sequencing; Mutation; Cancer; Somatic cell; DNA sequencing; Germline mutation; Cancer research; Cancer genome sequencing; Computational biology; Whole genome sequencing; Immunology","authors":[{"name":"Michael A. Chapman","is_ca":false},{"name":"Michael S. Lawrence","is_ca":false},{"name":"Jonathan J. Keats","is_ca":false},{"name":"Kristian Cibulskis","is_ca":false},{"name":"Carrie Sougnez","is_ca":false},{"name":"Anna C. Schinzel","is_ca":false},{"name":"Christina L. Harview","is_ca":false},{"name":"Jean-Philippe Brunet","is_ca":false},{"name":"Gregory Ahmann","is_ca":false},{"name":"Mazhar Adli","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false},{"name":"Kristin Ardlie","is_ca":false},{"name":"Daniel Auclair","is_ca":false},{"name":"Angela Baker","is_ca":false},{"name":"P. Leif Bergsagel","is_ca":false},{"name":"B Bernstein","is_ca":false},{"name":"Yotam Drier","is_ca":false},{"name":"Rafaël Fonseca","is_ca":false},{"name":"Stacey Gabriel","is_ca":false},{"name":"Craig C. Hofmeister","is_ca":false},{"name":"Sundar Jagannath","is_ca":false},{"name":"Andrzej Jakubowiak","is_ca":false},{"name":"Amrita Krishnan","is_ca":false},{"name":"Joan Levy","is_ca":false},{"name":"Ted Liefeld","is_ca":false},{"name":"Sagar Lonial","is_ca":false},{"name":"Scott Mahan","is_ca":false},{"name":"Bunmi Mfuko","is_ca":false},{"name":"Stefano Monti","is_ca":false},{"name":"Louise M. Perkins","is_ca":false},{"name":"Robb Onofrio","is_ca":false},{"name":"Trevor J. Pugh","is_ca":false},{"name":"S. Vincent Rajkumar","is_ca":false},{"name":"Alex H. Ramos","is_ca":false},{"name":"David S. Siegel","is_ca":false},{"name":"Andrey Sivachenko","is_ca":false},{"name":"A. Keith Stewart","is_ca":false},{"name":"Suzanne Trudel","is_ca":true},{"name":"Ravi Vij","is_ca":false},{"name":"Douglas Voet","is_ca":false},{"name":"Wendy Winckler","is_ca":false},{"name":"Todd M. Zimmerman","is_ca":false},{"name":"John D. Carpten","is_ca":false},{"name":"J.M. Trent","is_ca":false},{"name":"William C. Hahn","is_ca":false},{"name":"Levi A. Garraway","is_ca":false},{"name":"Matthew Meyerson","is_ca":false},{"name":"Eric S. Lander","is_ca":false},{"name":"Gad Getz","is_ca":false},{"name":"Todd R. Golub","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04615722236335353,"gpt":0.3260179922858882,"spread":0.2798607699225347,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001103094,0.0005299612,0.0007668754,0.00143817,0.0005451483,0.0007765176,0.0004543029,0.0009564665,0.001509296],"category_scores_gemma":[0.002219178,0.000331685,0.0009848108,0.001577002,0.0002052093,0.0002980059,0.0009932379,0.001144968,0.000998518],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000916711,"about_ca_system_score_gemma":0.0009764628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006033359,"about_ca_topic_score_gemma":0.006993963,"domain_scores_codex":[0.9989744,0.0001259106,0.00005657316,0.0003102845,0.0004245242,0.0001082762],"domain_scores_gemma":[0.9990778,0.0002036358,0.00009205075,0.0001292533,0.0004102825,0.00008695704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001586916,0.0001990077,0.06447307,0.002359309,0.001255399,0.001885522,0.001031964,0.007075481,0.5901551,0.00392663,0.04131783,0.2847337],"study_design_scores_gemma":[0.000230015,0.000674381,0.3288533,0.0005338949,0.0009693371,0.003416852,0.0005001373,0.01407513,0.2126781,0.006588249,0.4313245,0.0001560525],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6173172,0.04036717,0.1157434,0.005815002,0.001335417,0.001020466,0.1970579,0.004605813,0.0167377],"genre_scores_gemma":[0.6245881,0.01854859,0.1762686,0.005188598,0.0003827783,0.0008620457,0.162047,0.001050234,0.01106402],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006033359,"threshold_uncertainty_score":0.01199651,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2528329272","doi":"10.1056/nejmoa1607751","title":"Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1434,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"Otsuka Pharmaceutical; Celgene; Bristol-Myers Squibb; Incyte; Chugai Pharmaceutical; Spectrum Pharmaceuticals; Amgen","keywords":"Daratumumab; Lenalidomide; Dexamethasone; Multiple myeloma; Medicine; Oncology; Internal medicine","authors":[{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Hareth Nahi","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Saad Z. Usmani","is_ca":false},{"name":"Neil Rabin","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"Mieczysław Komarnicki","is_ca":false},{"name":"Kenshi Suzuki","is_ca":false},{"name":"Torben Plesner","is_ca":false},{"name":"Sung‐Soo Yoon","is_ca":false},{"name":"Dina Ben Yehuda","is_ca":false},{"name":"Paul G. Richardson","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Donna Reece","is_ca":true},{"name":"Steen Lisby","is_ca":false},{"name":"Nushmia Z. Khokhar","is_ca":false},{"name":"Lisa O’Rourke","is_ca":false},{"name":"Christopher Chiu","is_ca":false},{"name":"Xiang Qin","is_ca":false},{"name":"Mary Guckert","is_ca":false},{"name":"Tahamtan Ahmadi","is_ca":false},{"name":"Philippe Moreau","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04367413013929703,"gpt":0.3284536669106923,"spread":0.2847795367713952,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005938794,0.0003142081,0.0005044341,0.0002720236,0.0001560111,0.0002897183,0.0002307735,0.0002622318,0.002547282],"category_scores_gemma":[0.0004411493,0.00008514807,0.0003789613,0.0002337114,0.0001588919,0.0001557146,0.0002311469,0.0006673049,0.0003205246],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003416321,"about_ca_system_score_gemma":0.0004760861,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004671815,"about_ca_topic_score_gemma":0.002115115,"domain_scores_codex":[0.9997779,0.00009416139,0.00002378288,0.00003383393,0.00004792916,0.00002239451],"domain_scores_gemma":[0.9998528,0.0000327492,0.00004665417,0.000005705805,0.00001105406,0.00005104956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.06650926,0.003356765,0.0110004,0.002558672,0.00138516,0.0004506664,0.00006452194,0.001172488,0.01625215,0.0006648802,0.006272155,0.8903129],"study_design_scores_gemma":[0.3674867,0.2332868,0.1486652,0.001934199,0.004322062,0.008179151,0.000171137,0.003672789,0.02155102,0.002968886,0.2076626,0.00009933842],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7151625,0.2689753,0.0007530772,0.00428043,0.001257833,0.000812621,0.0004176029,0.0000858876,0.008254738],"genre_scores_gemma":[0.9501569,0.0408882,0.002191876,0.001895781,0.0005303305,0.0002723043,0.0004966379,0.000008340612,0.003559612],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002547282,"threshold_uncertainty_score":0.008521557,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985864219","doi":"10.1056/nejmoa1411321","title":"Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1324,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Lenalidomide; Medicine; Dexamethasone; Multiple myeloma; Oncology; Proteasome inhibitor; Internal medicine; Pharmacology","authors":[{"name":"A. Keith Stewart","is_ca":false},{"name":"S. Vincent Rajkumar","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Tamás Masszi","is_ca":false},{"name":"Ivan Špıčka","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Roman Hájek","is_ca":false},{"name":"Laura Rosiñol","is_ca":false},{"name":"David S. Siegel","is_ca":false},{"name":"Georgi Mihaylov","is_ca":false},{"name":"Vesselina Goranova‐Marinova","is_ca":false},{"name":"Péter Rajnics","is_ca":false},{"name":"Aleksandr Suvorov","is_ca":false},{"name":"Rubén Niesvizky","is_ca":false},{"name":"Andrzej Jakubowiak","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false},{"name":"Heinz Ludwig","is_ca":false},{"name":"Michael Wang","is_ca":false},{"name":"Vladimír Maisnar","is_ca":false},{"name":"Jiří Minařík","is_ca":false},{"name":"William Bensinger","is_ca":false},{"name":"María-Victoria Mateos","is_ca":false},{"name":"Dina Ben‐Yehuda","is_ca":false},{"name":"Vishal Kukreti","is_ca":true},{"name":"Naseem J. Zojwalla","is_ca":false},{"name":"Margaret Tonda","is_ca":false},{"name":"Xinqun Yang","is_ca":false},{"name":"Biao Xing","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Antonio Palumbo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03364004799786217,"gpt":0.3132240272849626,"spread":0.2795839792871004,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001012333,0.0003526796,0.0008491093,0.000345709,0.0002126015,0.0002376437,0.0003257906,0.0004102707,0.001948542],"category_scores_gemma":[0.0008977024,0.0001069939,0.0005077227,0.0003143037,0.0003101746,0.0001572912,0.0001811458,0.000739561,0.0002350356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006736927,"about_ca_system_score_gemma":0.000678929,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006768106,"about_ca_topic_score_gemma":0.002373797,"domain_scores_codex":[0.9996011,0.0001928022,0.00002987402,0.00005616624,0.00007266754,0.00004734505],"domain_scores_gemma":[0.9996624,0.0001074413,0.00008120603,0.00001700675,0.00001870412,0.0001132659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2190874,0.005779602,0.04005739,0.001840473,0.002099654,0.000854922,0.0001161456,0.002132666,0.01094565,0.0007334762,0.008500088,0.7078525],"study_design_scores_gemma":[0.3059684,0.2828933,0.3062409,0.0007546344,0.00388259,0.00680829,0.0001995877,0.005010855,0.008999147,0.002981653,0.07616528,0.00009537723],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9066323,0.08573885,0.0006831985,0.002846814,0.0005036562,0.000519369,0.0002975086,0.00006865072,0.002709603],"genre_scores_gemma":[0.9846455,0.01187643,0.0008895517,0.0007346635,0.00034183,0.0002402043,0.0003670832,0.000004734616,0.0008999894],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001948542,"threshold_uncertainty_score":0.006518483,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2201190784","doi":"10.1056/nejmoa1505654","title":"Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1320,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Dalhousie University","funders":"AbbVie Biotherapeutics; Bristol-Myers Squibb","keywords":"Lenalidomide; Medicine; Internal medicine; Multiple myeloma; Progression-free survival; Oncology; Neutropenia; Hazard ratio; Bortezomib; Dexamethasone; Confidence interval; Chemotherapy","authors":[{"name":"Sagar Lonial","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Antonio Palumbo","is_ca":false},{"name":"Darrell White","is_ca":true},{"name":"Sebastian Grosicki","is_ca":false},{"name":"Ivan Špıčka","is_ca":false},{"name":"Adam Walter‐Croneck","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Hila Magen","is_ca":false},{"name":"Andrew R. Belch","is_ca":true},{"name":"Donna Reece","is_ca":true},{"name":"Meral Beksaç","is_ca":false},{"name":"Andrew Spencer","is_ca":false},{"name":"Heather Oakervee","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"Masafumi Taniwaki","is_ca":false},{"name":"Christoph Röllig","is_ca":false},{"name":"Hermann Einsele","is_ca":false},{"name":"Ka Lung Wu","is_ca":false},{"name":"Anil Singhal","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false},{"name":"Morio Matsumoto","is_ca":false},{"name":"Jessica Katz","is_ca":false},{"name":"Eric Bleickardt","is_ca":false},{"name":"Valerie Poulart","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false},{"name":"Paul G. Richardson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09997258122392107,"gpt":0.365146460681726,"spread":0.265173879457805,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006438798,0.0003975139,0.0009354794,0.0003140072,0.0002620131,0.0002410194,0.0003056586,0.0003034359,0.001391976],"category_scores_gemma":[0.0005135647,0.00008099729,0.0003400737,0.0002851248,0.0002266437,0.0001606207,0.0002044231,0.0004877088,0.000314455],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006029469,"about_ca_system_score_gemma":0.0002840737,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002089879,"about_ca_topic_score_gemma":0.0005802418,"domain_scores_codex":[0.9998007,0.0000678696,0.00002131735,0.00002906579,0.00004676988,0.00003434544],"domain_scores_gemma":[0.9998337,0.00005536696,0.00004939538,0.0000109312,0.00001186074,0.00003870408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.07570059,0.006833416,0.04021426,0.00227533,0.001530987,0.003690834,0.0004831071,0.004354277,0.05961322,0.0006750262,0.005700724,0.7989283],"study_design_scores_gemma":[0.2174842,0.244204,0.331786,0.001151662,0.003354262,0.02618555,0.0003484936,0.01200489,0.04804987,0.003671702,0.1116394,0.0001199133],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9833407,0.01392675,0.0006179089,0.0003266571,0.00006992619,0.0002009323,0.0001267848,0.0000424284,0.001347843],"genre_scores_gemma":[0.9924787,0.004724553,0.0008633718,0.0004586055,0.0001324992,0.0001749779,0.0003807949,0.000006039217,0.0007804141],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001391976,"threshold_uncertainty_score":0.004656613,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2021954218","doi":"10.1056/nejmoa070596","title":"Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1235,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Lenalidomide; Medicine; Multiple myeloma; Dexamethasone; Internal medicine; Oncology","authors":[{"name":"Donna M. Weber","is_ca":false},{"name":"Christine Chen","is_ca":false},{"name":"Rubén Niesvizky","is_ca":false},{"name":"Michael Wang","is_ca":false},{"name":"Andrew R. Belch","is_ca":false},{"name":"Edward A. Stadtmauer","is_ca":false},{"name":"David S. Siegel","is_ca":false},{"name":"Ivan Borrello","is_ca":false},{"name":"S. Vincent Rajkumar","is_ca":false},{"name":"Asher Chanan‐Khan","is_ca":false},{"name":"Sagar Lonial","is_ca":false},{"name":"Zhinuan Yu","is_ca":false},{"name":"John Patin","is_ca":false},{"name":"Marta Olesnyckyj","is_ca":false},{"name":"Jerome B. Zeldis","is_ca":false},{"name":"Robert Knight","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03906187277418626,"gpt":0.3303583747850792,"spread":0.291296502010893,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005576039,0.000228997,0.0005081274,0.0002721056,0.0005966597,0.0002507941,0.0003386087,0.0002929988,0.002700079],"category_scores_gemma":[0.0005482903,0.0001202519,0.0002248889,0.0004336288,0.0003286886,0.0001440637,0.0003823289,0.0004313921,0.0004265257],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001076228,"about_ca_system_score_gemma":0.001672272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00474784,"about_ca_topic_score_gemma":0.02130876,"domain_scores_codex":[0.9997991,0.00008389199,0.00001849514,0.00003465178,0.00003618497,0.00002764984],"domain_scores_gemma":[0.9996856,0.00004560363,0.00007890956,0.00001178835,0.00003851037,0.0001395812],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.03011571,0.004705807,0.1620329,0.002983916,0.00117854,0.00694181,0.0008949516,0.001088176,0.02289579,0.00144163,0.03781883,0.7279019],"study_design_scores_gemma":[0.04818487,0.04479216,0.601881,0.00281517,0.002585624,0.03555728,0.001432551,0.001620543,0.006663491,0.002256185,0.2521118,0.00009927939],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8850056,0.08558461,0.0009459261,0.005892288,0.0007027482,0.0009510667,0.0005489574,0.0001212396,0.02024757],"genre_scores_gemma":[0.9665078,0.02231367,0.002223599,0.0045906,0.0005589432,0.0004377324,0.0004870461,0.00001861766,0.002862044],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00474784,"threshold_uncertainty_score":0.009440422,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4282033105","doi":"10.1056/nejmoa2203478","title":"Teclistamab in Relapsed or Refractory Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1114,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Institute of Cancer Research; Hotel Dieu Hospital","funders":"Janssen Research and Development; Winship Cancer Institute; School of Medicine, Stanford University; Cancer Center Amsterdam; Centro de Investigación Biomédica en Red de Cáncer; Eberhard Karls Universität Tübingen; National Cancer Institute; Institut d’Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona; Emory University; Universidad de Navarra; University College London; Memorial Sloan-Kettering Cancer Center; Perelman School of Medicine, University of Pennsylvania; Universitat de Barcelona; Vrije Universiteit Amsterdam; University of Pennsylvania; University of California, San Francisco; Comprehensive Cancer Center, City of Hope; National Institute for Health and Care Research; Leukemia and Lymphoma Society","keywords":"Multiple myeloma; Refractory (planetary science); Antibody; Cancer research; Antigen; Medicine; CD3; Immunology; Biology; CD8","authors":[{"name":"Philippe Moreau","is_ca":true},{"name":"Alfred L. Garfall","is_ca":false},{"name":"Niels W.C.J. van de Donk","is_ca":false},{"name":"Hareth Nahi","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Ajay K. Nooka","is_ca":false},{"name":"Thomas G. Martin","is_ca":false},{"name":"Laura Rosiñol","is_ca":false},{"name":"Ajai Chari","is_ca":false},{"name":"Lionel Karlin","is_ca":false},{"name":"Lotfi Benboubker","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Rakesh Popat","is_ca":false},{"name":"Britta Besemer","is_ca":false},{"name":"Joaquín Martínez‐López","is_ca":false},{"name":"Surbhi Sidana","is_ca":false},{"name":"Michel Delforge","is_ca":false},{"name":"Lixia Pei","is_ca":false},{"name":"Danielle Trancucci","is_ca":false},{"name":"Raluca Verona","is_ca":false},{"name":"Suzette Girgis","is_ca":false},{"name":"Shun Xin Wang Lin","is_ca":false},{"name":"Yunsi Olyslager","is_ca":false},{"name":"Mindy Jaffe","is_ca":false},{"name":"Clarissa Uhlar","is_ca":false},{"name":"Tara Stephenson","is_ca":false},{"name":"Rian Van Rampelbergh","is_ca":false},{"name":"Arnob Banerjee","is_ca":false},{"name":"Jenna D. Goldberg","is_ca":false},{"name":"Rachel Kobos","is_ca":false},{"name":"Amrita Krishnan","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04050119126847216,"gpt":0.323883615450082,"spread":0.2833824241816098,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005216761,0.0003260594,0.0007517164,0.0002719925,0.0002159989,0.0002467207,0.0002430845,0.0002794173,0.0008406009],"category_scores_gemma":[0.0004209543,0.00008822742,0.0003099109,0.0002770413,0.0001822176,0.0001787619,0.0001722712,0.0004677322,0.0002378293],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004453702,"about_ca_system_score_gemma":0.0002903975,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004627081,"about_ca_topic_score_gemma":0.001052591,"domain_scores_codex":[0.9998308,0.00005811462,0.00001670728,0.00002195495,0.00003547973,0.00003684224],"domain_scores_gemma":[0.9998253,0.00004263138,0.00005173759,0.00001062434,0.00001275047,0.00005697874],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.08265459,0.006155193,0.1627071,0.002138512,0.001520404,0.00733201,0.000812541,0.006071168,0.1396529,0.0003705174,0.006504834,0.5840802],"study_design_scores_gemma":[0.05644342,0.232417,0.5480763,0.0005839604,0.002201228,0.03206566,0.0003966354,0.01180091,0.07212692,0.0007283706,0.04306267,0.00009692593],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914013,0.007429725,0.0001313921,0.0001368471,0.0000249666,0.00004991347,0.00007028182,0.00002876202,0.0007269342],"genre_scores_gemma":[0.9973781,0.001702011,0.0001794799,0.0001450769,0.00005004973,0.00002568597,0.0002217309,0.000003752964,0.0002941824],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008406009,"threshold_uncertainty_score":0.003231347,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2343386476","doi":"10.1056/nejmoa1516282","title":"Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1054,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; University of Calgary; Hotel Dieu Hospital","funders":"Takeda Oncology","keywords":"Lenalidomide; Ixazomib; Medicine; Multiple myeloma; Dexamethasone; Oncology; Internal medicine; Dermatology; Pharmacology; Carfilzomib","authors":[{"name":"Philippe Moreau","is_ca":true},{"name":"Tamás Masszi","is_ca":false},{"name":"Norbert Grząśko","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Markus Hansson","is_ca":false},{"name":"Luděk Pour","is_ca":false},{"name":"Irwindeep Sandhu","is_ca":true},{"name":"Peter Ganly","is_ca":false},{"name":"Bartrum W. Baker","is_ca":false},{"name":"Sharon Jackson","is_ca":false},{"name":"Anne-Marie Stoppa","is_ca":false},{"name":"David R. Simpson","is_ca":false},{"name":"Peter Gimsing","is_ca":false},{"name":"Antonio Palumbo","is_ca":false},{"name":"Laurent Garderet","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Cyrille Touzeau","is_ca":true},{"name":"Francis K. Buadi","is_ca":false},{"name":"Jacob P. Laubach","is_ca":false},{"name":"Deborah Berg","is_ca":false},{"name":"Jianchang Lin","is_ca":false},{"name":"Alessandra Di Bacco","is_ca":false},{"name":"Ai-Min Hui","is_ca":false},{"name":"Helgi van de Velde","is_ca":false},{"name":"Paul G. Richardson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05120611506231794,"gpt":0.3360375626803982,"spread":0.2848314476180803,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007037501,0.0004717602,0.001156082,0.0003649201,0.0002107854,0.0004486931,0.0003903971,0.000517356,0.004580839],"category_scores_gemma":[0.0005996659,0.0002106658,0.0004675486,0.000358112,0.0005866899,0.0002322976,0.0002739956,0.001133273,0.0003572142],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004322704,"about_ca_system_score_gemma":0.0006129079,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005998076,"about_ca_topic_score_gemma":0.001724364,"domain_scores_codex":[0.9997312,0.0001125043,0.00002427271,0.00004254919,0.00004657031,0.0000428292],"domain_scores_gemma":[0.999715,0.00008282167,0.00008855252,0.00001288742,0.00000957581,0.00009120459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7254654,0.01038014,0.004550754,0.003173781,0.001260186,0.000179453,0.00008346821,0.001505419,0.02117324,0.0004161489,0.001515366,0.2302967],"study_design_scores_gemma":[0.7313552,0.2466388,0.009432257,0.0002745319,0.0009187883,0.0003682736,0.00005886172,0.0006984865,0.004465152,0.0003023681,0.005463498,0.00002371565],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9515408,0.04370195,0.0004985807,0.0007983158,0.000410045,0.000790338,0.0002368279,0.00005585428,0.001967219],"genre_scores_gemma":[0.9817634,0.01481598,0.0008323682,0.0003892811,0.0003952275,0.0003669622,0.0002452371,0.000006959589,0.001184512],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004580839,"threshold_uncertainty_score":0.01532441,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2947874495","doi":"10.1056/nejmoa1817249","title":"Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma","year":2019,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":987,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; University of Calgary","funders":"Janssen Research and Development; National Cancer Institute; Incyte; Celgene; Gilead Sciences; Pharmacyclics; Sanofi; Bristol-Myers Squibb; Chugai Pharmaceutical; Amgen","keywords":"Daratumumab; Lenalidomide; Dexamethasone; Multiple myeloma; Medicine; Oncology; Internal medicine","authors":[{"name":"Thierry Façon","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Torben Plesner","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Supratik Basu","is_ca":false},{"name":"Hareth Nahi","is_ca":false},{"name":"Cyrille Hulin","is_ca":false},{"name":"Hang Quach","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Michael O’Dwyer","is_ca":false},{"name":"Aurore Perrot","is_ca":false},{"name":"Christopher P. Venner","is_ca":true},{"name":"Katja Weisel","is_ca":false},{"name":"Joseph R. Mace","is_ca":false},{"name":"Noopur Raje","is_ca":false},{"name":"Michel Attal","is_ca":false},{"name":"Mourad Tiab","is_ca":false},{"name":"Margaret Macro","is_ca":false},{"name":"Laurent Frenzel","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Tahamtan Ahmadi","is_ca":false},{"name":"Christopher Chiu","is_ca":false},{"name":"Jianping Wang","is_ca":false},{"name":"Rian Van Rampelbergh","is_ca":false},{"name":"Clarissa Uhlar","is_ca":false},{"name":"Rachel Kobos","is_ca":false},{"name":"Ming Qi","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03083090465145425,"gpt":0.32272611846995,"spread":0.2918952138184958,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007127285,0.0002635336,0.0007895131,0.0002577188,0.0004109361,0.0002948008,0.000251973,0.0003494816,0.002903779],"category_scores_gemma":[0.001100408,0.0001238747,0.0005462684,0.0002798586,0.0002235191,0.0001672421,0.0002122819,0.0005859779,0.0004359242],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005017184,"about_ca_system_score_gemma":0.0008315357,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006869576,"about_ca_topic_score_gemma":0.002182798,"domain_scores_codex":[0.9996064,0.0001530352,0.00005010915,0.0000666448,0.00006891251,0.00005491565],"domain_scores_gemma":[0.9994137,0.0001978765,0.0001539911,0.00002796448,0.00002479232,0.0001816146],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2406954,0.0089371,0.1207011,0.002350327,0.002253875,0.001896321,0.0003721701,0.002592118,0.01638616,0.0007619302,0.006153072,0.5969004],"study_design_scores_gemma":[0.2384086,0.2926579,0.3744699,0.0009675256,0.003131007,0.01000883,0.0003120783,0.004041502,0.009827049,0.002151866,0.06391801,0.0001057885],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980412,0.01504672,0.0004084878,0.0006205089,0.0002110689,0.0005761549,0.0002400373,0.00002446235,0.002460596],"genre_scores_gemma":[0.993943,0.00296106,0.0009213282,0.0005973909,0.0001543754,0.0002236325,0.0002650294,0.000004091837,0.0009299825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002903779,"threshold_uncertainty_score":0.009714127,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2015880063","doi":"10.1038/leu.2009.174","title":"International Myeloma Working Group molecular classification of multiple myeloma: spotlight review","year":2009,"lang":"en","type":"review","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":878,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Saint John Regional Hospital; Dalhousie University","funders":"National Cancer Institute; National Institute on Aging","keywords":"Multiple myeloma; Chromosomal translocation; Biology; Cancer research; Hematology; Cytogenetics; Comparative genomic hybridization; Gene expression profiling; Gene; Oncology; Genetics; Chromosome; Immunology; Gene expression; Medicine","authors":[{"name":"Rafaël Fonseca","is_ca":false},{"name":"P. Leif Bergsagel","is_ca":false},{"name":"Johannes Drach","is_ca":false},{"name":"John D. Shaughnessy","is_ca":false},{"name":"Norma C. Gutiérrez","is_ca":false},{"name":"A. Keith Stewart","is_ca":false},{"name":"Gareth J. Morgan","is_ca":false},{"name":"Brian Van Ness","is_ca":false},{"name":"Marta Chesi","is_ca":false},{"name":"Stéphane Minvielle","is_ca":false},{"name":"Antonino Neri","is_ca":false},{"name":"Bart Barlogie","is_ca":false},{"name":"W. Michael Kuehl","is_ca":false},{"name":"Peter Liebisch","is_ca":false},{"name":"Faith E. Davies","is_ca":false},{"name":"Selina Chen‐Kiang","is_ca":false},{"name":"Brian G.M. Durie","is_ca":false},{"name":"Ruben D. Carrasco","is_ca":false},{"name":"Orhan Sezer","is_ca":false},{"name":"Tony Reiman","is_ca":true},{"name":"Linda M. Pilarski","is_ca":true},{"name":"Hervé Avet‐Loiseau","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0645365481067835,"gpt":0.3601065434952254,"spread":0.2955699953884419,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009542347,0.001081254,0.002686157,0.003639985,0.0003349967,0.001207412,0.001473699,0.001223812,0.003314438],"category_scores_gemma":[0.001351686,0.0003781879,0.000903121,0.004355028,0.0005269586,0.001556726,0.0008495423,0.002165096,0.001855009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001359239,"about_ca_system_score_gemma":0.003076854,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004403515,"about_ca_topic_score_gemma":0.00618586,"domain_scores_codex":[0.9996897,0.00005265904,0.00006494652,0.00005244734,0.000105605,0.0000346923],"domain_scores_gemma":[0.9992762,0.0002360715,0.0001254437,0.00001262844,0.0002821639,0.00006740805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001523852,0.00007115108,0.0004578514,0.01735322,0.0001657335,0.0001934491,0.00003346834,0.0002650538,0.0007168148,0.001159847,0.1077992,0.8716318],"study_design_scores_gemma":[0.00007688794,0.00009161414,0.001747466,0.007586715,0.0004902642,0.001305601,0.00008527716,0.0001173927,0.000269559,0.001157596,0.9870406,0.00003111662],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005771558,0.9983379,0.0000913663,0.0005427405,0.0004364425,0.000007916741,0.00003341608,0.000007052357,0.0004853914],"genre_scores_gemma":[0.0003352522,0.9984747,0.0002234188,0.0003141448,0.0003317518,0.000006827389,0.00007201007,0.000001081031,0.0002409199],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004403515,"threshold_uncertainty_score":0.01108789,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162771614","doi":"10.1093/annonc/mdx096","title":"Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":872,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"Cilag; Celgene; Chugai Pharmaceutical; Amgen; Pfizer; European Society for Medical Oncology; Bristol-Myers Squibb","keywords":"Medicine; Multiple myeloma; Monoclonal gammopathy of undetermined significance; Asymptomatic; Stage (stratigraphy); Incidence (geometry); Scopus; Internal medicine; MEDLINE; Monoclonal; Immunology","authors":[{"name":"Philippe Moreau","is_ca":true},{"name":"Jesús F. San Miguel","is_ca":false},{"name":"Pieter Sonneveld","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Elena Zamagni","is_ca":false},{"name":"Hervé Avet‐Loiseau","is_ca":false},{"name":"Roman Hájek","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Heinz Ludwig","is_ca":false},{"name":"Hermann Einsele","is_ca":false},{"name":"Sonja Zweegman","is_ca":false},{"name":"Thierry Façon","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Evangelos Terpos","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Michel Attal","is_ca":false},{"name":"Christian Buske","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4685253170586109,"gpt":0.5882108824589835,"spread":0.1196855654003726,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01070542,0.001387437,0.002276559,0.006682284,0.001853306,0.00265067,0.003041669,0.006213326,0.009599292],"category_scores_gemma":[0.04404072,0.0008356208,0.002967546,0.005090121,0.000729373,0.002268165,0.003993016,0.005125954,0.008235677],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003937256,"about_ca_system_score_gemma":0.01236857,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02005952,"about_ca_topic_score_gemma":0.03593719,"domain_scores_codex":[0.9890297,0.003528502,0.004104395,0.0003985793,0.002321995,0.0006168382],"domain_scores_gemma":[0.9652581,0.007163087,0.005506266,0.0007393986,0.01926572,0.002067551],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002552842,0.0003428439,0.0122009,0.001857253,0.0002118222,0.0003896697,0.000315018,0.001386684,0.0004396793,0.002884876,0.7250443,0.2546717],"study_design_scores_gemma":[0.0005186116,0.000197738,0.03561797,0.01963289,0.0006019786,0.002537605,0.0007807064,0.002572734,0.0007736943,0.01070466,0.9259102,0.0001512032],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.009516549,0.2493458,0.05151297,0.4759233,0.01609261,0.005196709,0.01916558,0.00310368,0.1701428],"genre_scores_gemma":[0.08860257,0.2534077,0.3979262,0.1291839,0.01671029,0.01693073,0.0412183,0.001320954,0.05469945],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.02005952,"threshold_uncertainty_score":0.05661631,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211191410","doi":"10.1016/s0140-6736(21)00135-5","title":"Multiple myeloma","year":2021,"lang":"en","type":"review","venue":"The Lancet","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":852,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Janssen Pharmaceuticals; Bayer; Celgene; Takeda Canada; Novartis; Cancer Research UK; Roche Products; Servier; Amgen","keywords":"Multiple myeloma; Medicine; Internal medicine","authors":[{"name":"Niels W.C.J. van de Donk","is_ca":false},{"name":"Charlotte Pawlyn","is_ca":false},{"name":"Kwee Yong","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1541464891673331,"gpt":0.4120173834667758,"spread":0.2578708942994428,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007551847,0.001262216,0.002022072,0.002911446,0.0004648341,0.001998331,0.0007963273,0.002107897,0.02990012],"category_scores_gemma":[0.002149074,0.0003756647,0.0008629666,0.002719499,0.0004480629,0.001345461,0.001424426,0.00298424,0.01452174],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001447438,"about_ca_system_score_gemma":0.00272178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0032268,"about_ca_topic_score_gemma":0.007417282,"domain_scores_codex":[0.9994665,0.000117217,0.00006797319,0.00007883164,0.0002000679,0.00006941843],"domain_scores_gemma":[0.9993482,0.0002053343,0.0001261592,0.00003156791,0.0002015987,0.00008712537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001283104,0.00002885958,0.00006624232,0.0135246,0.0001191256,0.0000778772,0.00002719056,0.00007960609,0.000410391,0.001711541,0.3026061,0.6812202],"study_design_scores_gemma":[0.00008849562,0.00004662053,0.0002712672,0.006192022,0.0001549083,0.0003086548,0.00001904611,0.00002191977,0.00007637505,0.0008871773,0.9919258,0.000007840833],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003318011,0.9915488,0.00006597771,0.001205655,0.002190392,0.00001390525,0.0000632088,0.00002206085,0.004856784],"genre_scores_gemma":[0.0008838733,0.9830847,0.0002158616,0.003989943,0.002307161,0.00002593082,0.000165547,0.000006356469,0.009320587],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02990012,"threshold_uncertainty_score":0.1000258,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2229483068","doi":"10.1016/s0140-6736(15)01120-4","title":"Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial","year":2016,"lang":"en","type":"article","venue":"The Lancet","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":850,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Royal Victoria Hospital; University of British Columbia; Hôpital Maisonneuve-Rosemont; University of Calgary","funders":"","keywords":"Daratumumab; Medicine; Multiple myeloma; Refractory (planetary science); Internal medicine; Clinical endpoint; Clinical trial; Phases of clinical research; Surrogate endpoint; Proteasome inhibitor; Surgery; Gastroenterology; Oncology; Lenalidomide","authors":[{"name":"Sagar Lonial","is_ca":false},{"name":"Brendan M. Weiss","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false},{"name":"Seema Singhal","is_ca":false},{"name":"Ajai Chari","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Andrew R. Belch","is_ca":false},{"name":"Amrita Krishnan","is_ca":false},{"name":"Robert Vescio","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Amitabha Mazumder","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"Heather J. Sutherland","is_ca":true},{"name":"Joan Bladé","is_ca":false},{"name":"Emma C. Scott","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Jesús G. Berdeja","is_ca":false},{"name":"Mecide Gharibo","is_ca":false},{"name":"Don A. Stevens","is_ca":false},{"name":"Richard LeBlanc","is_ca":true},{"name":"Michaël Sébag","is_ca":true},{"name":"Natalie S. Callander","is_ca":false},{"name":"Andrzej Jakubowiak","is_ca":false},{"name":"Darrell White","is_ca":true},{"name":"Javier de la Rubia","is_ca":false},{"name":"Paul G. Richardson","is_ca":false},{"name":"Steen Lisby","is_ca":false},{"name":"Huaibao Feng","is_ca":false},{"name":"Clarissa Uhlar","is_ca":false},{"name":"Imran Khan","is_ca":false},{"name":"Tahamtan Ahmadi","is_ca":false},{"name":"Peter M. Voorhees","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07518314198563648,"gpt":0.3707187301208377,"spread":0.2955355881352012,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002049053,0.002079323,0.003683257,0.0003659059,0.000456232,0.001314022,0.000807407,0.002124461,0.005780953],"category_scores_gemma":[0.001794409,0.000788444,0.002807385,0.0004036874,0.001179964,0.001261408,0.0005704027,0.00329354,0.001177887],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007546128,"about_ca_system_score_gemma":0.0009010539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008435485,"about_ca_topic_score_gemma":0.001953314,"domain_scores_codex":[0.9992487,0.0004180716,0.00004314239,0.0001317009,0.00004996331,0.0001084831],"domain_scores_gemma":[0.9991735,0.0002927266,0.0001884774,0.00006521137,0.00004871871,0.0002314529],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9858664,0.001653404,0.0004400277,0.0007581651,0.001388685,0.00004505857,0.00005410737,0.0002104054,0.001434633,0.00009946887,0.0007803895,0.00726927],"study_design_scores_gemma":[0.9790869,0.0187613,0.0008627688,0.00002890765,0.0004673479,0.00003013397,0.00001653429,0.0001269038,0.00009517266,0.00009077638,0.0004239842,0.000009359315],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9791569,0.0113297,0.0006371333,0.001519142,0.001119459,0.002251835,0.001409409,0.0001340638,0.002442351],"genre_scores_gemma":[0.9787726,0.006965518,0.002054409,0.002457047,0.0008904976,0.002756733,0.001872904,0.0000354752,0.004194884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005780953,"threshold_uncertainty_score":0.01933926,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2193716145","doi":"10.1016/s1470-2045(15)00464-7","title":"Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study","year":2015,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":849,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; London Health Sciences Centre","funders":"Cilag; Onyx Pharmaceuticals; Amgen; Takeda Oncology; Spectrum Pharmaceuticals; Array BioPharma; Janssen Pharmaceuticals; Genentech; Celgene; Sanofi; Bristol-Myers Squibb; Chugai Pharmaceutical","keywords":"Carfilzomib; Medicine; Bortezomib; Dexamethasone; Multiple myeloma; Clinical endpoint; Internal medicine; Refractory (planetary science); Population; Tolerability; Interim analysis; Oncology; Surgery; Clinical trial; Adverse effect","authors":[{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Antonio Palumbo","is_ca":false},{"name":"Douglas Joshua","is_ca":false},{"name":"Luděk Pour","is_ca":false},{"name":"Roman Hájek","is_ca":false},{"name":"Thierry Façon","is_ca":false},{"name":"Heinz Ludwig","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Laura Rosiñol","is_ca":false},{"name":"Jan Štraub","is_ca":false},{"name":"Aleksandr Suvorov","is_ca":false},{"name":"Carla Araujo","is_ca":false},{"name":"Elena Rimashevskaya","is_ca":false},{"name":"Tomáš Pika","is_ca":false},{"name":"Gianluca Gaïdano","is_ca":false},{"name":"Katja Weisel","is_ca":false},{"name":"Vesselina Goranova‐Marinova","is_ca":false},{"name":"Anthony P. Schwarer","is_ca":false},{"name":"Leonard Minuk","is_ca":true},{"name":"Tamás Masszi","is_ca":false},{"name":"Ievgenii Karamanesht","is_ca":false},{"name":"Massimo Offidani","is_ca":false},{"name":"Vânia Hungria","is_ca":false},{"name":"Andrew Spencer","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"Heidi H. Gillenwater","is_ca":false},{"name":"Nehal Mohamed","is_ca":false},{"name":"Shibao Feng","is_ca":false},{"name":"Wee Joo Chng","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1799697924150374,"gpt":0.430217007053223,"spread":0.2502472146381857,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002791215,0.002176891,0.003897764,0.0005564123,0.0005658571,0.001540889,0.00114855,0.002531665,0.006898107],"category_scores_gemma":[0.002563141,0.001014983,0.003129876,0.0007061108,0.002049039,0.0017519,0.0006779901,0.00373368,0.001060344],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001308133,"about_ca_system_score_gemma":0.001352547,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00211373,"about_ca_topic_score_gemma":0.003785914,"domain_scores_codex":[0.9988343,0.0006613501,0.00005904277,0.000175874,0.00007716618,0.0001922806],"domain_scores_gemma":[0.9981672,0.0006943588,0.000333605,0.000153105,0.00008640549,0.0005653087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9908525,0.002834152,0.0002459292,0.0001965723,0.000475571,0.00001395591,0.00002940704,0.0001669185,0.0008068974,0.00004913258,0.0002442997,0.00408476],"study_design_scores_gemma":[0.9452491,0.05287846,0.0009179775,0.00001418656,0.0002935567,0.00001438982,0.00001954676,0.0001508738,0.00009891058,0.0000790531,0.0002723785,0.0000115485],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892279,0.004348198,0.0004488696,0.000880453,0.0006727825,0.001995433,0.0008623562,0.00008159514,0.001482406],"genre_scores_gemma":[0.9889577,0.002544512,0.00113768,0.00125639,0.0007229033,0.002025351,0.000939247,0.00002193026,0.002394316],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006898107,"threshold_uncertainty_score":0.02307647,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2136541422","doi":"10.1016/s1470-2045(13)70380-2","title":"Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":799,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"Celgene","keywords":"Pomalidomide; Dexamethasone; Medicine; Lenalidomide; Refractory (planetary science); Internal medicine; Multiple myeloma; Clinical endpoint; Bortezomib; Population; Thalidomide; Progressive disease; Clinical trial; Phases of clinical research; Oncology; Gastroenterology; Chemotherapy","authors":[{"name":"Jesús F. San Miguel","is_ca":false},{"name":"Katja Weisel","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Martha Q. Lacy","is_ca":false},{"name":"Kevin Song","is_ca":true},{"name":"Michel Delforge","is_ca":false},{"name":"Lionel Karlin","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Anne Banos","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Adrían Alegre","is_ca":false},{"name":"Christine Chen","is_ca":true},{"name":"Michèle Cavo","is_ca":false},{"name":"Laurent Garderet","is_ca":false},{"name":"Valentina Ivanova","is_ca":false},{"name":"Joaquín Martínez‐López","is_ca":false},{"name":"Andrew R. Belch","is_ca":true},{"name":"Antonio Palumbo","is_ca":false},{"name":"Stephen Schey","is_ca":false},{"name":"Pieter Sonneveld","is_ca":false},{"name":"Xin Yu","is_ca":false},{"name":"Lars Sternås","is_ca":false},{"name":"Christian Jacques","is_ca":false},{"name":"Mohamed H. Zaki","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08314179518883183,"gpt":0.3790846202528805,"spread":0.2959428250640487,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002151439,0.002722625,0.003762455,0.0005222539,0.0005407553,0.001731629,0.001763945,0.002382675,0.009994194],"category_scores_gemma":[0.002124199,0.000897209,0.003731199,0.0007176638,0.002066078,0.001744676,0.000779404,0.005390675,0.001620145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001614057,"about_ca_system_score_gemma":0.001437796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002265129,"about_ca_topic_score_gemma":0.003978742,"domain_scores_codex":[0.9992623,0.000385938,0.00003920473,0.0001441617,0.0000481532,0.000120353],"domain_scores_gemma":[0.9989422,0.0003529156,0.0002095811,0.00008147049,0.00003659866,0.0003773166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9886956,0.002267034,0.0002116398,0.0003173516,0.0006636717,0.00002119473,0.00003902381,0.0002481049,0.0007869022,0.00009040855,0.0006345232,0.006024588],"study_design_scores_gemma":[0.9786839,0.01991208,0.0004613813,0.00001867459,0.0002260165,0.00001688505,0.00001441083,0.0001777979,0.00008989887,0.0001614097,0.0002281124,0.000009437439],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9800875,0.006784879,0.0007802942,0.002023343,0.001266805,0.003595009,0.002160327,0.0002382363,0.003063537],"genre_scores_gemma":[0.9847719,0.002936242,0.001725687,0.001931795,0.0006236575,0.002858542,0.001296234,0.00004526437,0.003810605],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009994194,"threshold_uncertainty_score":0.03343385,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2995934717","doi":"10.1016/s1470-2045(19)30788-0","title":"Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":796,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"UCLH Biomedical Research Centre; National Institute for Health and Care Research; Seattle Genetics; GlaxoSmithKline; U.S. Department of Veterans Affairs","keywords":"Medicine; Internal medicine; Refractory (planetary science); Population; Multiple myeloma; Discontinuation; Toxicity; Phases of clinical research; Gastroenterology; Oncology; Surgery","authors":[{"name":"Sagar Lonial","is_ca":false},{"name":"Hans C. Lee","is_ca":false},{"name":"Ashraf Badros","is_ca":false},{"name":"Suzanne Trudel","is_ca":true},{"name":"Ajay K. Nooka","is_ca":false},{"name":"Ajai Chari","is_ca":false},{"name":"Al‐Ola Abdallah","is_ca":false},{"name":"Natalie S. Callander","is_ca":false},{"name":"Nikoletta Lendvai","is_ca":false},{"name":"Douglas W. Sborov","is_ca":false},{"name":"Attaya Suvannasankha","is_ca":false},{"name":"Katja Weisel","is_ca":false},{"name":"Lionel Karlin","is_ca":false},{"name":"Edward N. Libby","is_ca":false},{"name":"Bertrand Arnulf","is_ca":false},{"name":"Thierry Façon","is_ca":false},{"name":"Cyrille Hulin","is_ca":false},{"name":"K. Martin Kortüm","is_ca":false},{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false},{"name":"Parameswaran Hari","is_ca":false},{"name":"Rachid Baz","is_ca":false},{"name":"Hang Quach","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Peter M. Voorhees","is_ca":false},{"name":"Ira Gupta","is_ca":false},{"name":"Axel Hoos","is_ca":false},{"name":"Eric Zhi","is_ca":false},{"name":"January Baron","is_ca":false},{"name":"Trisha Piontek","is_ca":false},{"name":"Eric Lewis","is_ca":false},{"name":"Roxanne C. Jewell","is_ca":false},{"name":"Elisha J. Dettman","is_ca":false},{"name":"Rakesh Popat","is_ca":false},{"name":"Simona Degli Esposti","is_ca":false},{"name":"Joanna Opalinska","is_ca":false},{"name":"Paul G. Richardson","is_ca":false},{"name":"Adam D. Cohen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1334839683588592,"gpt":0.452415809330682,"spread":0.3189318409718228,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002344539,0.002166352,0.003500912,0.0005138098,0.0003950815,0.001286108,0.001241801,0.002006968,0.00758782],"category_scores_gemma":[0.001476521,0.0009757181,0.002126217,0.000384864,0.001361912,0.001905129,0.00061792,0.003497451,0.001619245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001005589,"about_ca_system_score_gemma":0.001037643,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008629506,"about_ca_topic_score_gemma":0.001635019,"domain_scores_codex":[0.9992618,0.0003848498,0.00003020971,0.0001174856,0.00006294978,0.000142748],"domain_scores_gemma":[0.9993443,0.0001886244,0.000120101,0.00007776303,0.00003452067,0.0002346971],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9611711,0.01067624,0.0003975401,0.0006136991,0.0008162075,0.00004371824,0.00006628364,0.0004859287,0.004158867,0.0002326188,0.001003256,0.02033465],"study_design_scores_gemma":[0.944246,0.05338847,0.0007216007,0.00001641883,0.0002068123,0.00003918868,0.00001798094,0.0003055216,0.0002520701,0.0001775332,0.0006126759,0.00001583424],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878787,0.00406339,0.0009700633,0.0009456806,0.0005690603,0.002512936,0.001075712,0.0001839083,0.0018005],"genre_scores_gemma":[0.9764891,0.004210787,0.003201398,0.001702612,0.0005311192,0.005516571,0.001689042,0.00006607998,0.006593105],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00758782,"threshold_uncertainty_score":0.02538377,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2141105112","doi":"10.1056/nejmoa1402551","title":"Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":786,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Princess Margaret Cancer Centre; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Lenalidomide; Thalidomide; Dexamethasone; Multiple myeloma; Prednisone; Melphalan; Oncology; Internal medicine; Hematopoietic stem cell transplantation; Transplantation","authors":[{"name":"Lotfi Benboubker","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Angela Dispenzieri","is_ca":false},{"name":"John Catalano","is_ca":false},{"name":"Andrew R. Belch","is_ca":true},{"name":"Michèle Cavo","is_ca":false},{"name":"Katja Weisel","is_ca":false},{"name":"Heinz Ludwig","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Anne Banos","is_ca":false},{"name":"Mourad Tiab","is_ca":false},{"name":"Michel Delforge","is_ca":false},{"name":"Jamie Cavenagh","is_ca":false},{"name":"Catarina Geraldes","is_ca":false},{"name":"Je‐Jung Lee","is_ca":false},{"name":"Christine Chen","is_ca":true},{"name":"Albert Oriol","is_ca":false},{"name":"Javier de la Rubia","is_ca":false},{"name":"Lugui Qiu","is_ca":false},{"name":"Darrell White","is_ca":true},{"name":"Daniel Binder","is_ca":false},{"name":"Kenneth Anderson","is_ca":false},{"name":"Jean-Paul Fermand","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Michel Attal","is_ca":false},{"name":"Robert Knight","is_ca":false},{"name":"Guang Chen","is_ca":false},{"name":"Jason Van Oostendorp","is_ca":false},{"name":"Christian Jacques","is_ca":false},{"name":"Annette Ervin‐Haynes","is_ca":false},{"name":"Hervé Avet‐Loiseau","is_ca":false},{"name":"Cyrille Hulin","is_ca":false},{"name":"Thierry Façon","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01396461102567876,"gpt":0.2676388465394127,"spread":0.2536742355137339,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001808777,0.0003247091,0.0009861346,0.0002323377,0.0003876331,0.0007213005,0.0003867213,0.0006915152,0.001590028],"category_scores_gemma":[0.00303397,0.0001796936,0.0006155537,0.0003912658,0.0005499861,0.000353048,0.0003590081,0.001278292,0.0002524059],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006068228,"about_ca_system_score_gemma":0.001044545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004863078,"about_ca_topic_score_gemma":0.001250501,"domain_scores_codex":[0.9992201,0.0004795917,0.00007812867,0.00008632811,0.00005465794,0.00008117235],"domain_scores_gemma":[0.9982162,0.0006828331,0.0004475921,0.00006443737,0.00003491951,0.0005541038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4716542,0.007274196,0.2632113,0.001344149,0.001211738,0.001389712,0.0004810949,0.004102304,0.006647968,0.0006205218,0.003454917,0.2386081],"study_design_scores_gemma":[0.1898015,0.37694,0.3841418,0.0009958493,0.002805297,0.005921085,0.0009109291,0.005740176,0.005738997,0.003398948,0.02347746,0.0001278864],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9815754,0.01536225,0.0002595198,0.001070684,0.0001326247,0.0002580528,0.0002202806,0.00001858753,0.001102742],"genre_scores_gemma":[0.9969347,0.001566609,0.0003853605,0.0005603742,0.00009446783,0.0001202097,0.0002161423,0.000002763516,0.0001194301],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001808777,"threshold_uncertainty_score":0.00956583,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2048483323","doi":"10.1182/blood-2014-12-615187","title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report","year":2015,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":762,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Multiple myeloma; Medicine; Internal medicine; Lenalidomide; Oncology; Intensive care medicine","authors":[{"name":"Antonio Palumbo","is_ca":false},{"name":"Sara Bringhen","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Alessandra Larocca","is_ca":false},{"name":"Thierry Façon","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Massimo Offidani","is_ca":false},{"name":"Philip L. McCarthy","is_ca":false},{"name":"Andrea Evangelista","is_ca":false},{"name":"Sagar Lonial","is_ca":false},{"name":"Sonja Zweegman","is_ca":false},{"name":"Pellegrino Musto","is_ca":false},{"name":"Evangelos Terpos","is_ca":false},{"name":"Andrew Belch","is_ca":true},{"name":"Roman Hájek","is_ca":false},{"name":"Heinz Ludwig","is_ca":false},{"name":"A. Keith Stewart","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false},{"name":"Hermann Einsele","is_ca":false},{"name":"Brian G.M. Durie","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Ola Landgren","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false},{"name":"Paul G. Richardson","is_ca":false},{"name":"Pieter Sonneveld","is_ca":false},{"name":"S. Vincent Rajkumar","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03792475166351981,"gpt":0.317462271230351,"spread":0.2795375195668311,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01572324,0.000981163,0.002278382,0.002626185,0.0002768285,0.001233151,0.0004903144,0.0005419519,0.0006666248],"category_scores_gemma":[0.01506948,0.0003975377,0.005395437,0.003745399,0.0002483501,0.0006210278,0.0009225145,0.0003909375,0.0001102235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004320078,"about_ca_system_score_gemma":0.0005132674,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001952961,"about_ca_topic_score_gemma":0.003404822,"domain_scores_codex":[0.994981,0.002588172,0.0009097225,0.0007298935,0.000612407,0.0001788104],"domain_scores_gemma":[0.9883431,0.003645069,0.005365299,0.001412932,0.0009014086,0.0003322815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004971181,0.00003628839,0.8933874,0.0009597291,0.06971329,0.00007820552,0.00004963664,0.001196327,0.0002645373,0.00005787405,0.001408609,0.02787702],"study_design_scores_gemma":[0.0009002023,0.0007169432,0.9255511,0.0004338743,0.06737176,0.0003520375,0.00005673481,0.001373603,0.0002465971,0.0002510187,0.002701995,0.00004418671],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8118182,0.1732887,0.003182602,0.0007485537,0.0001561444,0.0001861594,0.00818124,0.00006711845,0.002371264],"genre_scores_gemma":[0.9794545,0.01309579,0.001116569,0.0004177122,0.0003239925,0.0001501122,0.005199009,0.00002208966,0.0002201819],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01572324,"threshold_uncertainty_score":0.08315343,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2166508172","doi":"10.1158/0008-5472.can-03-2876","title":"Genetics and Cytogenetics of Multiple Myeloma","year":2004,"lang":"en","type":"article","venue":"Cancer Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":686,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta","funders":"National Cancer Institute","keywords":"Monoclonal gammopathy of undetermined significance; Multiple myeloma; Biology; Chromosomal translocation; Cytogenetics; Genetics; Immunology; Cancer research; Chromosome; Monoclonal; Gene; Antibody; Monoclonal antibody","authors":[{"name":"Rafaël Fonseca","is_ca":false},{"name":"Bart Barlogie","is_ca":false},{"name":"Régis Bataille","is_ca":false},{"name":"Christian Bastard","is_ca":false},{"name":"P. Leif Bergsagel","is_ca":false},{"name":"Marta Chesi","is_ca":false},{"name":"Faith E. Davies","is_ca":false},{"name":"Johannes Drach","is_ca":false},{"name":"Philip R. Greipp","is_ca":false},{"name":"Ilan R. Kirsch","is_ca":false},{"name":"W. Michael Kuehl","is_ca":false},{"name":"Jesús María Hernández‐Rivas","is_ca":false},{"name":"Stéphane Minvielle","is_ca":false},{"name":"Linda M. Pilarski","is_ca":true},{"name":"John D. Shaughnessy","is_ca":false},{"name":"A. Keith Stewart","is_ca":true},{"name":"Hervé Avet‐Loiseau","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1273650904996298,"gpt":0.4379651948271182,"spread":0.3106001043274884,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003291869,0.0002978826,0.0003672375,0.002516871,0.0003148909,0.0005834266,0.0003733595,0.0007256717,0.001230175],"category_scores_gemma":[0.001093854,0.0002527738,0.0002535791,0.001841782,0.0009408891,0.0006417179,0.0006611043,0.0007834056,0.0003399545],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009790577,"about_ca_system_score_gemma":0.0006243355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003980115,"about_ca_topic_score_gemma":0.00212359,"domain_scores_codex":[0.9995753,0.0001039538,0.00003228599,0.00008726334,0.000150713,0.0000504008],"domain_scores_gemma":[0.9995704,0.0001144434,0.0001423062,0.00003527113,0.00007740309,0.00006010519],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0008667072,0.0001509934,0.2048058,0.001555211,0.0003724271,0.03139969,0.00226014,0.009418648,0.1658902,0.09454593,0.02307256,0.4656617],"study_design_scores_gemma":[0.00007664378,0.0004621498,0.3917323,0.0004974849,0.0002095177,0.1643619,0.001242707,0.00177413,0.01568185,0.09294578,0.3308517,0.0001637099],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.4358942,0.4494255,0.01784875,0.02476636,0.0007516156,0.0001202745,0.001362943,0.0006060099,0.06922428],"genre_scores_gemma":[0.8715955,0.1128709,0.005757669,0.001749399,0.0007205638,0.00005243207,0.0005415176,0.00004957763,0.006662434],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003980115,"threshold_uncertainty_score":0.007913888,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2089311432","doi":"10.1182/blood-2012-05-425934","title":"A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":655,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; University of Calgary; University of Toronto","funders":"National Cancer Institute; Jewish General Hospital; Onyx Pharmaceuticals; University of Alberta; Wake Forest University","keywords":"Carfilzomib; Multiple myeloma; Refractory (planetary science); Medicine; Pomalidomide; Lenalidomide; Oncology; Internal medicine; Materials science","authors":[{"name":"David S. Siegel","is_ca":false},{"name":"Thomas G. Martin","is_ca":false},{"name":"Michael Wang","is_ca":false},{"name":"Ravi Vij","is_ca":false},{"name":"Andrzej Jakubowiak","is_ca":false},{"name":"Sagar Lonial","is_ca":false},{"name":"Suzanne Trudel","is_ca":true},{"name":"Vishal Kukreti","is_ca":true},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Melissa Alsina","is_ca":false},{"name":"Asher Chanan‐Khan","is_ca":false},{"name":"Francis K. Buadi","is_ca":false},{"name":"Frederic J. Reu","is_ca":false},{"name":"George Somlo","is_ca":false},{"name":"Jeffrey A. Zonder","is_ca":false},{"name":"Kevin Song","is_ca":true},{"name":"A. Keith Stewart","is_ca":false},{"name":"Edward A. Stadtmauer","is_ca":false},{"name":"Lori Kunkel","is_ca":false},{"name":"Sandra Wear","is_ca":false},{"name":"Alvin Wong","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"Sundar Jagannath","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02848352810245834,"gpt":0.2876643652637208,"spread":0.2591808371612624,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001171719,0.001441639,0.001797245,0.0004150797,0.000327659,0.0005490789,0.0006843164,0.001002092,0.003382487],"category_scores_gemma":[0.000630284,0.0004528907,0.0008602787,0.0003032401,0.0006524614,0.0005925098,0.0002824011,0.00198024,0.0006810595],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006431729,"about_ca_system_score_gemma":0.00121169,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007518679,"about_ca_topic_score_gemma":0.001778697,"domain_scores_codex":[0.9997316,0.0001146217,0.000009804813,0.00005348074,0.00003220671,0.00005828612],"domain_scores_gemma":[0.999561,0.00007543664,0.00008744613,0.00002707658,0.00002304867,0.0002260229],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5729035,0.1321645,0.0116318,0.001198575,0.001036432,0.001107777,0.0005864388,0.003819877,0.07944411,0.0004871304,0.006156135,0.1894637],"study_design_scores_gemma":[0.4308757,0.5435147,0.01538811,0.00002576699,0.0002647142,0.0007179359,0.00005755942,0.001785384,0.003964499,0.0001861933,0.0031912,0.00002806779],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928878,0.001472812,0.0005680483,0.0002658686,0.00006106021,0.002775102,0.000647817,0.0001071226,0.001214436],"genre_scores_gemma":[0.9861866,0.001868644,0.002254616,0.0007928513,0.0001844682,0.003342507,0.002526839,0.0000285535,0.002814798],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003382487,"threshold_uncertainty_score":0.01131552,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2127143739","doi":"10.1182/blood.v99.3.731","title":"Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial","year":2002,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":566,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Melphalan; Total body irradiation; Medicine; Transplantation; Conditioning; Surgery; Stem cell; Peripheral Blood Stem Cells; Peripheral blood; Hematopoietic stem cell transplantation; Chemotherapy; Internal medicine; Cyclophosphamide; Biology","authors":[{"name":"Philippe Moreau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01493534316314259,"gpt":0.2591304528636316,"spread":0.244195109700489,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00168423,0.0009691429,0.001572689,0.0003397184,0.0001856358,0.0009496789,0.0007397928,0.001066064,0.002535853],"category_scores_gemma":[0.001158628,0.0003194925,0.001550351,0.0003163503,0.0005154295,0.0006860825,0.0003276246,0.001744542,0.000366024],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008154336,"about_ca_system_score_gemma":0.0006926437,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007045315,"about_ca_topic_score_gemma":0.002045332,"domain_scores_codex":[0.9990356,0.0006683999,0.00004811552,0.0001030723,0.00005613976,0.00008875543],"domain_scores_gemma":[0.9992597,0.00021922,0.0001865206,0.0000493083,0.00002307318,0.0002621599],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9584132,0.005948836,0.002621428,0.0003127396,0.001370994,0.00004184601,0.00005113984,0.0006869402,0.003145196,0.0001069646,0.0006407235,0.02665987],"study_design_scores_gemma":[0.7777013,0.199467,0.0179346,0.00008769306,0.001261681,0.00009622864,0.00005319402,0.001278438,0.0007504445,0.0002658704,0.001076648,0.00002686077],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951484,0.003245581,0.0001205517,0.0002529825,0.0001335667,0.0002250545,0.0001500236,0.00001546549,0.0007083361],"genre_scores_gemma":[0.9955355,0.001744559,0.0003485322,0.0005588589,0.0002303605,0.0003229234,0.00044714,0.000009620423,0.0008025476],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002535853,"threshold_uncertainty_score":0.008907199,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385839624","doi":"10.1038/s41591-023-02528-9","title":"Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":564,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Genentech; Cilag; Astellas Pharma; Regeneron Pharmaceuticals; Bristol-Myers Squibb; AstraZeneca; CSL Behring; Adaptive Biotechnologies; Karyopharm Therapeutics; AstraZeneca España; Sanofi; Legend Biotech; Celgene; Amgen; Pfizer","keywords":"Medicine; Neutropenia; Dosing; Internal medicine; Adverse effect; Clinical endpoint; Multiple myeloma; Anemia; Cytokine release syndrome; Gastroenterology; Refractory (planetary science); Lenalidomide; Clinical trial; Surgery; Cancer; Chemotherapy; Immunotherapy; Chimeric antigen receptor","authors":[{"name":"Alexander M. Lesokhin","is_ca":false},{"name":"Michael H. Tomasson","is_ca":false},{"name":"Bertrand Arnulf","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"H. Miles Prince","is_ca":false},{"name":"Rubén Niesvizky","is_ca":false},{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"Joaquín Martínez‐López","is_ca":false},{"name":"Guenther Koehne","is_ca":false},{"name":"Cyrille Touzeau","is_ca":false},{"name":"Yogesh Jethava","is_ca":false},{"name":"Hang Quach","is_ca":false},{"name":"Julien Depaus","is_ca":false},{"name":"Hisayuki Yokoyama","is_ca":false},{"name":"Afshin Eli Gabayan","is_ca":false},{"name":"Don A. Stevens","is_ca":false},{"name":"Ajay K. Nooka","is_ca":false},{"name":"Salomon Manier","is_ca":false},{"name":"Noopur Raje","is_ca":false},{"name":"Shinsuke Iida","is_ca":false},{"name":"Marc S. Raab","is_ca":false},{"name":"Emma Searle","is_ca":false},{"name":"Eric Leip","is_ca":false},{"name":"Sharon T. Sullivan","is_ca":false},{"name":"Umberto Conte","is_ca":false},{"name":"Mohamed Elmeliegy","is_ca":false},{"name":"Akos Czibere","is_ca":false},{"name":"Andrea Viqueira","is_ca":false},{"name":"Mohamad Mohty","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04440612642337285,"gpt":0.3940585836265068,"spread":0.3496524572031339,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003087562,0.0009545975,0.001371493,0.0002054468,0.0002369213,0.000794869,0.0005522278,0.0008877829,0.00230838],"category_scores_gemma":[0.000995634,0.0001924452,0.001075282,0.0002688609,0.000340571,0.0005088326,0.0002613951,0.001745156,0.0005607343],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006453131,"about_ca_system_score_gemma":0.0009767844,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004763883,"about_ca_topic_score_gemma":0.00129683,"domain_scores_codex":[0.9993993,0.0003186098,0.00003215669,0.00007348257,0.00008261167,0.00009387984],"domain_scores_gemma":[0.9996338,0.00008623834,0.00009522391,0.00003079025,0.00003109831,0.0001228982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.56829,0.01987899,0.01113516,0.002988495,0.00352334,0.000760737,0.0004300087,0.006368261,0.0533123,0.001134561,0.03116842,0.3010097],"study_design_scores_gemma":[0.7739692,0.1530699,0.03761122,0.0003318172,0.001779496,0.000926166,0.00006289978,0.003882897,0.006267151,0.001247525,0.02078702,0.00006465341],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9605983,0.02110049,0.001373148,0.002591029,0.0002676034,0.002728917,0.00381122,0.0003065579,0.00722271],"genre_scores_gemma":[0.9693975,0.007890866,0.00242035,0.003645614,0.0004223013,0.003383187,0.007941329,0.00008485041,0.004814053],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003087562,"threshold_uncertainty_score":0.01632881,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4281628749","doi":"10.1056/nejmoa2204925","title":"Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma","year":2022,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":463,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Knight Cancer Institute, Oregon Health and Science University; Houston Methodist Research Institute; Massachusetts General Hospital; Houston Methodist Hospital; Takeda Oncology; Winship Cancer Institute; State University of New York Upstate Medical University; Moffitt Cancer Center; Ohio State University; Barbara Ann Karmanos Cancer Institute; Comprehensive Cancer Center, City of Hope; Medical Center, University of Pittsburgh; Syracuse University; University of Pittsburgh; Memorial Sloan-Kettering Cancer Center; University of Washington; Roswell Park Cancer Institute; University of Pennsylvania; Celgene; U.S. Department of Veterans Affairs; Wayne State University; Takeda Pharmaceuticals North America; Emory University; Bristol-Myers Squibb; National Institutes of Health","keywords":"Medicine; Multiple myeloma; Lenalidomide; Transplantation; Melphalan; Hazard ratio; Autologous stem-cell transplantation; Surgery; Internal medicine; Bortezomib; Dexamethasone; Hematopoietic stem cell transplantation; Clinical endpoint; Randomized controlled trial; Confidence interval","authors":[{"name":"Paul G. Richardson","is_ca":false},{"name":"Susanna Jacobus","is_ca":false},{"name":"Edie Weller","is_ca":false},{"name":"Hani Hassoun","is_ca":false},{"name":"Sagar Lonial","is_ca":false},{"name":"Noopur Raje","is_ca":false},{"name":"Eva Medvedova","is_ca":false},{"name":"Philip L. McCarthy","is_ca":false},{"name":"Edward N. Libby","is_ca":false},{"name":"Peter M. Voorhees","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"Larry D. Anderson","is_ca":false},{"name":"Jeffrey A. Zonder","is_ca":false},{"name":"Carter P. Milner","is_ca":false},{"name":"Cristina Gasparetto","is_ca":false},{"name":"Mounzer Agha","is_ca":false},{"name":"Abdullah Khan","is_ca":false},{"name":"David D. Hurd","is_ca":false},{"name":"Krisstina Gowin","is_ca":false},{"name":"Rammurti T. Kamble","is_ca":false},{"name":"Sundar Jagannath","is_ca":false},{"name":"Nitya Nathwani","is_ca":false},{"name":"Melissa Alsina","is_ca":false},{"name":"Robert F. Cornell","is_ca":false},{"name":"Hamza Hashmi","is_ca":false},{"name":"Erica Campagnaro","is_ca":false},{"name":"Astrid C. Andreescu","is_ca":false},{"name":"Teresa Gentile","is_ca":false},{"name":"Michaela Liedtke","is_ca":false},{"name":"Kelly Godby","is_ca":false},{"name":"Adam D. Cohen","is_ca":false},{"name":"Thomas H. Openshaw","is_ca":false},{"name":"Marcelo C. Pasquini","is_ca":false},{"name":"Sergio Giralt","is_ca":false},{"name":"Jonathan L. Kaufman","is_ca":false},{"name":"Andrew J. Yee","is_ca":false},{"name":"Emma C. Scott","is_ca":false},{"name":"Pallawi Torka","is_ca":false},{"name":"Amy Foley","is_ca":false},{"name":"Mariateresa Fulciniti","is_ca":false},{"name":"Kyle Hebert","is_ca":false},{"name":"Mehmet Samur","is_ca":false},{"name":"Kelly Masone","is_ca":false},{"name":"Michelle E. Maglio","is_ca":false},{"name":"Andrea A. Zeytoonjian","is_ca":false},{"name":"Omar Nadeem","is_ca":false},{"name":"Robert Schlossman","is_ca":false},{"name":"Jacob P. Laubach","is_ca":false},{"name":"Claudia E. Paba‐Prada","is_ca":false},{"name":"Irene M. Ghobrial","is_ca":false},{"name":"Aurore Perrot","is_ca":false},{"name":"Philippe Moreau","is_ca":true},{"name":"Hervé Avet‐Loiseau","is_ca":false},{"name":"Michel Attal","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false},{"name":"Nikhil C. Munshi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02580289369441924,"gpt":0.3233462153975102,"spread":0.297543321703091,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001795974,0.0002398389,0.001057382,0.0002659649,0.0001915533,0.0003308039,0.0003729543,0.0005211175,0.001376938],"category_scores_gemma":[0.001665788,0.0001186277,0.0006293131,0.000335643,0.0004547941,0.0003367762,0.0004073447,0.001499913,0.000126171],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003227195,"about_ca_system_score_gemma":0.0004336305,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003200941,"about_ca_topic_score_gemma":0.0006883459,"domain_scores_codex":[0.9992987,0.0004316255,0.00004895197,0.00007360906,0.00009679281,0.00005024347],"domain_scores_gemma":[0.9989638,0.0004431695,0.00025544,0.0000701676,0.00002965354,0.0002377906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4097535,0.009130907,0.02206905,0.001662512,0.002708692,0.0002256012,0.000210514,0.005599509,0.009003683,0.0008570325,0.002534499,0.5362445],"study_design_scores_gemma":[0.2447985,0.6622783,0.06118771,0.0007525766,0.003096159,0.001911084,0.00008696388,0.007648309,0.005806542,0.002866933,0.009506046,0.00006099272],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9779882,0.01963876,0.0007258013,0.0003956563,0.0001564018,0.0001610708,0.00005788809,0.00003033262,0.0008458089],"genre_scores_gemma":[0.9940845,0.003975633,0.0007962764,0.0003804828,0.0001822918,0.0001640751,0.0001301435,0.000004452998,0.0002821203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001795974,"threshold_uncertainty_score":0.009498179,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3111394247","doi":"10.1182/bloodadvances.2020002827","title":"A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma","year":2020,"lang":"en","type":"review","venue":"Blood Advances","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":413,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Cilag; National Cancer Institute; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"Multiple myeloma; Term (time); Negativity effect; Meta-analysis; Oncology; Internal medicine; Survival analysis; Medicine; Psychology; Developmental psychology","authors":[{"name":"Nikhil C. Munshi","is_ca":false},{"name":"Hervé Avet‐Loiseau","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false},{"name":"Paola Neri","is_ca":true},{"name":"Bruno Paiva","is_ca":false},{"name":"Mehmet Samur","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Margarita Kulakova","is_ca":false},{"name":"Annette Lam","is_ca":false},{"name":"Mahmoud Hashim","is_ca":false},{"name":"Jianming He","is_ca":false},{"name":"Bart Heeg","is_ca":false},{"name":"Jon Ukropec","is_ca":false},{"name":"Jessica Vermeulen","is_ca":false},{"name":"Sarah Côté","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04332111366551855,"gpt":0.341869319960231,"spread":0.2985482062947124,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01649116,0.002270176,0.0098378,0.005333563,0.0006045172,0.003150518,0.001361904,0.00209895,0.001488451],"category_scores_gemma":[0.02841334,0.001168658,0.03390865,0.005680968,0.0006792503,0.001344539,0.001289699,0.001669871,0.0002036537],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001397773,"about_ca_system_score_gemma":0.001656853,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004670074,"about_ca_topic_score_gemma":0.01026996,"domain_scores_codex":[0.9910648,0.004697128,0.001975897,0.001215277,0.000763973,0.0002831256],"domain_scores_gemma":[0.975376,0.01851423,0.003494096,0.001200718,0.001103947,0.0003110025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002696342,0.0000228879,0.02847555,0.05396375,0.9048863,0.0001510586,0.00006139518,0.0006356722,0.0003322969,0.00007707359,0.0003423062,0.008355252],"study_design_scores_gemma":[0.0003106821,0.0002037065,0.01935007,0.003072938,0.9756599,0.00009520348,0.00002391883,0.0002249961,0.000107231,0.0001458593,0.0007891826,0.00001626602],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02784985,0.9700726,0.0006677235,0.0003271724,0.0001716276,0.00006852091,0.0005176748,0.00002847176,0.0002963446],"genre_scores_gemma":[0.6501892,0.3449579,0.001883195,0.0009338026,0.0004710825,0.0002861956,0.0009572206,0.00004072219,0.0002806475],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01649116,"threshold_uncertainty_score":0.08721465,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052645281","doi":"10.1016/j.ccr.2013.08.009","title":"Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma","year":2013,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":406,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Bortezomib; Proteasome inhibitor; Multiple myeloma; Endoplasmic reticulum; Proteasome; Cancer research; Plasma cell; Progenitor cell; Unfolded protein response; Biology; Antibody; Immunology; Cell biology; Stem cell","authors":[{"name":"Chungyee Leung-Hagesteijn","is_ca":true},{"name":"Natalie Erdmann","is_ca":true},{"name":"Grace W.C. Cheung","is_ca":true},{"name":"Jonathan J. Keats","is_ca":false},{"name":"A. Keith Stewart","is_ca":false},{"name":"Donna Reece","is_ca":true},{"name":"Kim Chan Chung","is_ca":true},{"name":"Rodger E. Tiedemann","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01708461497933192,"gpt":0.2672179697081689,"spread":0.250133354728837,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002990336,0.00027228,0.0003734032,0.0003856948,0.0003157516,0.0005697732,0.0003954994,0.0004454708,0.003091004],"category_scores_gemma":[0.0002358793,0.0002766206,0.0002077046,0.0002129844,0.0003350983,0.0003624778,0.0002967972,0.001450292,0.0008923511],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003437087,"about_ca_system_score_gemma":0.0001847985,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000487759,"about_ca_topic_score_gemma":0.000496257,"domain_scores_codex":[0.9997557,0.0000608419,0.00001672624,0.00003070893,0.00006543007,0.00007063885],"domain_scores_gemma":[0.9998921,0.0000285814,0.00001995695,0.00002424737,0.00001044513,0.00002467715],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008636139,0.000229825,0.0008650069,0.00003376812,0.00001575552,0.0001847058,0.000046876,0.000137846,0.9907991,0.0007170102,0.000559937,0.005546701],"study_design_scores_gemma":[0.0002928469,0.002306443,0.02368182,0.00001021278,0.00006217685,0.003179853,0.0002288359,0.002471536,0.9587439,0.0005192515,0.00848935,0.00001390361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941777,0.001642107,0.001019116,0.0002171365,0.00003244806,0.00003261165,0.0002087089,0.000102445,0.002567721],"genre_scores_gemma":[0.99686,0.0004358986,0.0004856526,0.00006081577,0.00001404366,0.00002428337,0.0001889598,0.00001514747,0.001915178],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003091004,"threshold_uncertainty_score":0.01034045,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2402003835","doi":"10.1182/blood-2016-03-705210","title":"Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":404,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Janssen Research and Development","keywords":"Daratumumab; Medicine; Refractory (planetary science); Carfilzomib; Internal medicine; Multiple myeloma; Oncology; Lenalidomide; Pomalidomide; Bortezomib","authors":[{"name":"Saad Z. Usmani","is_ca":false},{"name":"Brendan M. Weiss","is_ca":false},{"name":"Torben Plesner","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Andrew Belch","is_ca":false},{"name":"Sagar Lonial","is_ca":false},{"name":"Henk M. Lokhorst","is_ca":false},{"name":"Peter M. Voorhees","is_ca":false},{"name":"Paul G. Richardson","is_ca":false},{"name":"Ajai Chari","is_ca":false},{"name":"A. Kate Sasser","is_ca":false},{"name":"Amy Axel","is_ca":false},{"name":"Huaibao Feng","is_ca":false},{"name":"Clarissa Uhlar","is_ca":false},{"name":"Jianping Wang","is_ca":false},{"name":"Imran Khan","is_ca":false},{"name":"Tahamtan Ahmadi","is_ca":false},{"name":"Hareth Nahi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02828968112667683,"gpt":0.3204325270016135,"spread":0.2921428458749366,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003473892,0.0004854808,0.002340553,0.0009948796,0.0002475884,0.0008344408,0.0003129793,0.0004392993,0.000554561],"category_scores_gemma":[0.003936828,0.0003501706,0.001684288,0.001341991,0.000195187,0.0004473065,0.000382677,0.0005429048,0.0001383136],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004180984,"about_ca_system_score_gemma":0.0003540699,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006971061,"about_ca_topic_score_gemma":0.001914877,"domain_scores_codex":[0.9981634,0.0008635067,0.0003035944,0.0002891257,0.0003040583,0.00007637856],"domain_scores_gemma":[0.9977086,0.0007852719,0.001024797,0.0001560148,0.0001748928,0.000150568],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.04139677,0.0002777908,0.7928781,0.001273357,0.03627376,0.0006376457,0.000204532,0.002063191,0.01415348,0.00005096311,0.001522217,0.1092682],"study_design_scores_gemma":[0.002312414,0.007483164,0.971686,0.00007674669,0.01123444,0.001383145,0.00007051705,0.001333567,0.001293361,0.0000816581,0.00300769,0.00003726542],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9590872,0.03841194,0.0004402213,0.0001675212,0.00004054505,0.00006337751,0.0008967968,0.00003830073,0.0008540105],"genre_scores_gemma":[0.9956048,0.002630778,0.0002968213,0.0001468404,0.0001003197,0.00002533056,0.001080242,0.000007177573,0.0001077717],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003473892,"threshold_uncertainty_score":0.01837194,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2749746182","doi":"10.1016/s1470-2045(17)30578-8","title":"Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":401,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"CancerCare Manitoba","funders":"Onyx Pharmaceuticals; Amgen","keywords":"Carfilzomib; Bortezomib; Medicine; Interim analysis; Multiple myeloma; Dexamethasone; Proteasome inhibitor; Tolerability; Internal medicine; Refractory (planetary science); Clinical trial; Oncology; Surgery; Adverse effect","authors":[{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Rubén Niesvizky","is_ca":false},{"name":"Douglas Joshua","is_ca":false},{"name":"Wee Joo Chng","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"Heinz Ludwig","is_ca":false},{"name":"Thierry Façon","is_ca":false},{"name":"Roman Hájek","is_ca":false},{"name":"Katja Weisel","is_ca":false},{"name":"Vânia Hungria","is_ca":false},{"name":"Leonard Minuk","is_ca":true},{"name":"Shibao Feng","is_ca":false},{"name":"Anita Zahlten‐Kumeli","is_ca":false},{"name":"Amy Kimball","is_ca":false},{"name":"Philippe Moreau","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2558644524284098,"gpt":0.4978180911776169,"spread":0.2419536387492071,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006088896,0.001725193,0.00339705,0.0004438031,0.0005087209,0.001932046,0.0009740735,0.002327939,0.004439439],"category_scores_gemma":[0.004041462,0.0005410337,0.003664887,0.0005423664,0.001892424,0.002128522,0.0007580503,0.004023947,0.0009426304],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001315681,"about_ca_system_score_gemma":0.001418708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00124658,"about_ca_topic_score_gemma":0.003134419,"domain_scores_codex":[0.9975693,0.001614515,0.00008840112,0.0002521274,0.0001506803,0.0003250287],"domain_scores_gemma":[0.9967631,0.001407666,0.0005671912,0.0003144538,0.0001601798,0.0007874204],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9770904,0.001572312,0.0009280966,0.0002429051,0.001275222,0.00003564854,0.00005632326,0.0005812587,0.001131915,0.0001669071,0.001308417,0.01561054],"study_design_scores_gemma":[0.926241,0.06332015,0.005706734,0.00005621219,0.001424456,0.00008076489,0.0000482318,0.0006408431,0.0004367816,0.0005712516,0.001440153,0.00003347176],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9785696,0.009795321,0.001035929,0.002108804,0.0005309869,0.001306005,0.00251588,0.0001973589,0.003940165],"genre_scores_gemma":[0.9845829,0.002605586,0.001732576,0.002363971,0.0005174419,0.001438377,0.003954935,0.00005435163,0.002749908],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006088896,"threshold_uncertainty_score":0.03220153,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2096672426","doi":"10.1200/jco.2014.57.9961","title":"Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":394,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Cilag; Takeda Oncology; National Institutes of Health; National University Health System; Gachon University; Tel Aviv University; Ostravská Univerzita v Ostravě; Universidad de Salamanca; Eli Lilly and Company; National Taiwan University Hospital; Keio University; Northwestern University; York University; Nagoya City University; Cedars-Sinai Medical Center; University of Arkansas for Medical Sciences; Ankara Universitesi; National Taiwan University; National and Kapodistrian University of Athens; Karolinska Institutet; Memorial Sloan-Kettering Cancer Center; University of Alberta; Queen Mary University of London; Universität Wien; Emory University; Gil Medical Center, Gachon University; Universität Heidelberg; Celgene","keywords":"Medicine; Multiple myeloma; Magnetic resonance imaging; Radiology; Plasmacytoma; Bone marrow; Asymptomatic; Pathology; Internal medicine","authors":[{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Jens Hillengaß","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false},{"name":"Elena Zamagni","is_ca":false},{"name":"Suzanne Lentzsch","is_ca":false},{"name":"Faith E. Davies","is_ca":false},{"name":"Noopur Raje","is_ca":false},{"name":"Orhan Sezer","is_ca":false},{"name":"Sonja Zweegman","is_ca":false},{"name":"Jatin J. Shah","is_ca":false},{"name":"Ashraf Badros","is_ca":false},{"name":"Kazuyuki Shimizu","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Chor Sang Chim","is_ca":false},{"name":"Juan José Lahuerta","is_ca":false},{"name":"Jian Hou","is_ca":false},{"name":"Artur Jurczyszyn","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Pieter Sonneveld","is_ca":false},{"name":"Antonio Palumbo","is_ca":false},{"name":"Heinz Ludwig","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Bart Barlogie","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false},{"name":"G. David Roodman","is_ca":false},{"name":"S. Vincent Rajkumar","is_ca":false},{"name":"Brian G.M. Durie","is_ca":false},{"name":"Evangelos Terpos","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0815232574213156,"gpt":0.4278384350591133,"spread":0.3463151776377977,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03088516,0.001367965,0.00251211,0.003406879,0.001638913,0.002956417,0.004993892,0.009736518,0.001868956],"category_scores_gemma":[0.03437329,0.0006736391,0.002964386,0.002506515,0.001866739,0.003271245,0.004106078,0.01158568,0.002173356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003511199,"about_ca_system_score_gemma":0.01485538,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004543152,"about_ca_topic_score_gemma":0.004499178,"domain_scores_codex":[0.9852777,0.005516038,0.004359743,0.0008007771,0.003230852,0.0008149],"domain_scores_gemma":[0.9607847,0.009426137,0.00482882,0.0007168935,0.02051526,0.0037282],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001939788,0.0002545436,0.004944851,0.0115621,0.0003487582,0.0006495301,0.0005684065,0.001273333,0.0009269253,0.005814166,0.4900523,0.4834112],"study_design_scores_gemma":[0.0002735805,0.0002452907,0.007862124,0.06235428,0.0006537086,0.002213236,0.001084594,0.0009265899,0.0007965462,0.01076699,0.9126802,0.0001428552],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.002196093,0.3269069,0.006284222,0.6324258,0.02151431,0.0006060147,0.0008277246,0.0001645941,0.009074354],"genre_scores_gemma":[0.0368728,0.6007287,0.0569692,0.2575301,0.03325864,0.002187312,0.006354381,0.000175967,0.005922867],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.03088516,"threshold_uncertainty_score":0.1633383,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2945852816","doi":"10.1016/s1470-2045(19)30152-4","title":"Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":385,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"Celgene","keywords":"Pomalidomide; Lenalidomide; Dexamethasone; Bortezomib; Medicine; Refractory (planetary science); Multiple myeloma; Open label; Oncology; Internal medicine; Thalidomide; Randomized controlled trial; Biology","authors":[{"name":"Paul G. Richardson","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Meral Beksaç","is_ca":false},{"name":"Anna Marina Liberati","is_ca":false},{"name":"Mónica Galli","is_ca":false},{"name":"Fredrik Schjesvold","is_ca":false},{"name":"Jindriska Lindsay","is_ca":false},{"name":"Katja Weisel","is_ca":false},{"name":"Darrell White","is_ca":true},{"name":"Thierry Façon","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false},{"name":"Kazutaka Sunami","is_ca":false},{"name":"Peter O’Gorman","is_ca":false},{"name":"Pieter Sonneveld","is_ca":false},{"name":"Paweł Robak","is_ca":false},{"name":"С. В. Семочкин","is_ca":false},{"name":"Steve Schey","is_ca":false},{"name":"Xin Yu","is_ca":false},{"name":"Thomas Doerr","is_ca":false},{"name":"Amine Bensmaine","is_ca":false},{"name":"Tsvetan Biyukov","is_ca":false},{"name":"Teresa Peluso","is_ca":false},{"name":"Mohamed H. Zaki","is_ca":false},{"name":"Kenneth Anderson","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Niels Abildgaard","is_ca":false},{"name":"Howard L. Adler","is_ca":false},{"name":"Fevzi Altuntaş","is_ca":false},{"name":"Olga Meltem Akay","is_ca":false},{"name":"Bipinkumar Amin","is_ca":false},{"name":"Larry D. Anderson","is_ca":false},{"name":"Pekka Anttila","is_ca":false},{"name":"Carla Araujo","is_ca":false},{"name":"Carlos Arce‐Lara","is_ca":false},{"name":"Yıldız Aydın","is_ca":false},{"name":"Supratik Basu","is_ca":false},{"name":"Ramakrishna Battini","is_ca":false},{"name":"Thaddeus Beeker","is_ca":false},{"name":"Lotfi Benboubker","is_ca":false},{"name":"Dina Ben‐Yehuda","is_ca":false},{"name":"Joan Bladé","is_ca":false},{"name":"Igor Wolfgang Blau","is_ca":false},{"name":"Ralph V. Boccia","is_ca":false},{"name":"Lillian Burke","is_ca":false},{"name":"Peter D. Byeff","is_ca":false},{"name":"Nicola Cascavilla","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Andrew Chantry","is_ca":false},{"name":"Yen Charles","is_ca":false},{"name":"Arvind Chaudhry","is_ca":false},{"name":"Alessandro Corso","is_ca":false},{"name":"Mark Coyne","is_ca":false},{"name":"Felipe de Arriba","is_ca":false},{"name":"Sosana Delimpasi","is_ca":false},{"name":"Binod Dhakal","is_ca":false},{"name":"Paolo Di Bartolomeo","is_ca":false},{"name":"Francesco Di Raimondo","is_ca":false},{"name":"Jan Dürig","is_ca":false},{"name":"Monika Engelhardt","is_ca":false},{"name":"Martine Escoffre‐Barbe","is_ca":false},{"name":"Graça Esteves","is_ca":false},{"name":"Max Flogegård","is_ca":false},{"name":"Nashat Gabrail","is_ca":false},{"name":"Barbara Gamberi","is_ca":false},{"name":"Mitchell Garrison","is_ca":false},{"name":"Julie Gay","is_ca":false},{"name":"Heinz Gisslinger","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Cristina Gonçalves","is_ca":false},{"name":"Laurent Gressot","is_ca":false},{"name":"Sebastian Grosicki","is_ca":false},{"name":"Wahid T. Hanna","is_ca":false},{"name":"Patrick Hayden","is_ca":false},{"name":"Maria Manuela Henriques Bernardo","is_ca":false},{"name":"Róbert Hermann","is_ca":false},{"name":"Viran Holden","is_ca":false},{"name":"Kirsti Honkalehto","is_ca":false},{"name":"Marianne Huben","is_ca":false},{"name":"John Huffman","is_ca":false},{"name":"Hannah Hunter","is_ca":false},{"name":"Marek Hus","is_ca":false},{"name":"Madan Jagasia","is_ca":false},{"name":"Sundar Jagganath","is_ca":false},{"name":"Murali Janakiram","is_ca":false},{"name":"Ishmael Jaiyesimi","is_ca":false},{"name":"Matthew Jenner","is_ca":false},{"name":"Cristina João","is_ca":false},{"name":"Peter Johnson","is_ca":false},{"name":"Artur Jurcyszyn","is_ca":false},{"name":"Sevgi Kalayoğlu Beşışık","is_ca":false},{"name":"Suman Kambhampati","is_ca":false},{"name":"Abraham S. Kanate","is_ca":false},{"name":"Ìhsan Karadoǧan","is_ca":false},{"name":"Ali Khojasteh","is_ca":false},{"name":"Dean Kirkel","is_ca":false},{"name":"Mieczysław Komarnicki","is_ca":false},{"name":"Maria‐Theresa Krauth","is_ca":false},{"name":"Phillip Kuriakose","is_ca":false},{"name":"Alessandra Larocca","is_ca":false},{"name":"Birgitta Lauri","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Paulo Lúcio","is_ca":false},{"name":"Mario Luppi","is_ca":false},{"name":"Silvia Mangiacavalli","is_ca":false},{"name":"Clara Mariette","is_ca":false},{"name":"Kosei Matsue","is_ca":false},{"name":"Ulf-Henri Mellqvist","is_ca":false},{"name":"Л. П. Менделеева","is_ca":false},{"name":"Michael W. Meshad","is_ca":false},{"name":"Carole B. Miller","is_ca":false},{"name":"Ann Mohrbacher","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Anna Morelli","is_ca":false},{"name":"Ercan Müldür","is_ca":false},{"name":"Anthony E. Naassan","is_ca":false},{"name":"Hareth Nahi","is_ca":false},{"name":"Rajesh Nair","is_ca":false},{"name":"Mike O'Dwyer","is_ca":false},{"name":"Şeniz Öngören Aydın","is_ca":false},{"name":"Thomas H. Openshaw","is_ca":false},{"name":"Timothy J. O’Rourke","is_ca":false},{"name":"Michael B. Osswald","is_ca":false},{"name":"Lindsay Overton","is_ca":false},{"name":"Asmin Pati","is_ca":false},{"name":"Michel Pavic","is_ca":false},{"name":"Brigitte Pegourié","is_ca":false},{"name":"Mustafa Pehlıvan","is_ca":false},{"name":"Ana Alfonso Piérola","is_ca":false},{"name":"Torben Plesner","is_ca":false},{"name":"Andrzej Pluta","is_ca":false},{"name":"Neil Rabin","is_ca":false},{"name":"Karthik Ramasamy","is_ca":false},{"name":"Alessandro Rambaldi","is_ca":false},{"name":"Paula Rodríguez","is_ca":false},{"name":"Christoph Röllig","is_ca":false},{"name":"Jacalyn Rosenblatt","is_ca":false},{"name":"Jonathan Z Rosenbluth","is_ca":false},{"name":"Morten Salomo","is_ca":false},{"name":"Olga Samoylova","is_ca":false},{"name":"Jose Sastre Moral","is_ca":false},{"name":"Hamdi Sati","is_ca":false},{"name":"Carmine Selleri","is_ca":false},{"name":"Salim Shafeek","is_ca":false},{"name":"Atsushi Shinagawa","is_ca":false},{"name":"Bethany Sleckman","is_ca":false},{"name":"Clayton A. Smith","is_ca":false},{"name":"Mehmet Sönmez","is_ca":false},{"name":"Chester Stone","is_ca":false},{"name":"Matthew Streetly","is_ca":false},{"name":"Kenshi Suzuki","is_ca":false},{"name":"Raymond Taetle","is_ca":false},{"name":"Agostino Tafuri","is_ca":false},{"name":"Naoki Takezako","is_ca":false},{"name":"Hava Üsküdar Teke","is_ca":false},{"name":"Mirja Vapaatalo","is_ca":false},{"name":"George Vassilopoulos","is_ca":false},{"name":"Amit Verma","is_ca":false},{"name":"Sarah Vidito","is_ca":false},{"name":"Luísa Viterbo","is_ca":false},{"name":"Filiz Vural","is_ca":false},{"name":"Xiang Wang","is_ca":false},{"name":"Münci Yağcı","is_ca":false},{"name":"Andrew J. Yee","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07880100858038529,"gpt":0.3826707602881763,"spread":0.303869751707791,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001833491,0.001781466,0.002795597,0.0004059583,0.0004369658,0.001382263,0.0009696438,0.001887615,0.006277301],"category_scores_gemma":[0.001530411,0.0006735656,0.002951838,0.0004718634,0.00132126,0.001209466,0.0006448421,0.003593403,0.0009329004],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001174525,"about_ca_system_score_gemma":0.001278119,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001527751,"about_ca_topic_score_gemma":0.003681336,"domain_scores_codex":[0.9993759,0.0003351516,0.00003162118,0.0001131662,0.0000420164,0.000102156],"domain_scores_gemma":[0.9992989,0.0002114087,0.000140241,0.00004787642,0.00002752509,0.0002740271],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9792169,0.003182491,0.0005138399,0.0004674115,0.001085277,0.00003288553,0.0000550988,0.0003095558,0.001386098,0.0001162876,0.0008455428,0.0127887],"study_design_scores_gemma":[0.9766568,0.02142053,0.0008578377,0.0000237775,0.0002403321,0.00002112015,0.00001478372,0.0001480068,0.00008884243,0.0001363646,0.0003828766,0.000008723901],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9799774,0.009331343,0.0005360901,0.001622258,0.0008395786,0.003315513,0.001442391,0.0001372124,0.002798216],"genre_scores_gemma":[0.983526,0.004263879,0.001690813,0.00215909,0.0005745372,0.002994618,0.001485738,0.00002702345,0.003278463],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006277301,"threshold_uncertainty_score":0.02099961,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2075175917","doi":"10.1182/blood-2002-06-1675","title":"In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression","year":2003,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":384,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Chromosomal translocation; Multiple myeloma; Monoclonal gammopathy of undetermined significance; Fibroblast growth factor receptor 3; Biology; Bone marrow; Hazard ratio; Breakpoint; Internal medicine; Exon; Medicine; Molecular biology; Gastroenterology; Pathology; Immunology; Antibody; Monoclonal; Monoclonal antibody; Receptor; Fibroblast growth factor; Genetics; Gene","authors":[{"name":"Jonathan J. Keats","is_ca":true},{"name":"Tony Reiman","is_ca":true},{"name":"Christopher A. Maxwell","is_ca":true},{"name":"Brian J. Taylor","is_ca":true},{"name":"Loree Larratt","is_ca":true},{"name":"Michael J. Mant","is_ca":true},{"name":"Andrew R. Belch","is_ca":true},{"name":"Linda M. Pilarski","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.038379939079467,"gpt":0.3103475589323647,"spread":0.2719676198528976,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002776008,0.0002717532,0.0002664062,0.0005772609,0.0003071325,0.000329191,0.00030323,0.0005321144,0.001506654],"category_scores_gemma":[0.001472247,0.000177026,0.0001441187,0.0005466067,0.0003393361,0.0002866786,0.00027883,0.0002340448,0.0004733721],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000133547,"about_ca_system_score_gemma":0.0001311718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006157811,"about_ca_topic_score_gemma":0.000724016,"domain_scores_codex":[0.9997407,0.00005272474,0.00002986249,0.00007642225,0.00004878064,0.0000515867],"domain_scores_gemma":[0.9988783,0.0002140005,0.0006550106,0.00006404474,0.00006534972,0.0001232869],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002730086,0.000009354626,0.9926097,0.000009353921,0.00001639538,0.0006227114,0.0000393941,0.00002719384,0.00391779,0.00001208615,0.00004980223,0.002413256],"study_design_scores_gemma":[0.00001381388,0.0002526984,0.9875715,0.000004957731,0.00003506438,0.01033161,0.00009812288,0.0002100211,0.001016265,0.00005890616,0.000401572,0.000005482033],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994593,0.0002327676,0.00009234032,0.00001967547,0.000002592367,0.000002511787,0.00006491991,0.000003901645,0.0001218702],"genre_scores_gemma":[0.9996166,0.00007411987,0.00008040321,0.000008373278,0.00001114323,0.000002824304,0.0001201357,0.000001075663,0.00008525046],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001506654,"threshold_uncertainty_score":0.005040288,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2091773528","doi":"10.1182/blood-2013-11-538835","title":"Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":384,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; University of Alberta; University of Calgary; Royal Victoria Hospital; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Celgene","keywords":"Medicine; Pomalidomide; Lenalidomide; Neutropenia; Multiple myeloma; Internal medicine; Bortezomib; Population; Dexamethasone; Surgery; Febrile neutropenia; Thalidomide; Randomized controlled trial; Phases of clinical research; Chemotherapy","authors":[{"name":"Paul G. Richardson","is_ca":false},{"name":"David S. Siegel","is_ca":false},{"name":"Ravi Vij","is_ca":false},{"name":"Craig C. Hofmeister","is_ca":false},{"name":"Rachid Baz","is_ca":false},{"name":"Sundar Jagannath","is_ca":false},{"name":"Christine Chen","is_ca":true},{"name":"Sagar Lonial","is_ca":false},{"name":"Andrzej Jakubowiak","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Kevin Song","is_ca":true},{"name":"Andrew Belch","is_ca":true},{"name":"Noopur Raje","is_ca":false},{"name":"Chaim Shustik","is_ca":true},{"name":"Suzanne Lentzsch","is_ca":false},{"name":"Martha Q. Lacy","is_ca":false},{"name":"Joseph Mıkhael","is_ca":false},{"name":"Jeffrey Matous","is_ca":false},{"name":"David H. Vesole","is_ca":false},{"name":"Min Chen","is_ca":false},{"name":"Mohamed H. Zaki","is_ca":false},{"name":"Christian Jacques","is_ca":false},{"name":"Zhinuan Yu","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01876082933216229,"gpt":0.3065881242718411,"spread":0.2878272949396788,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003251018,0.002101016,0.003385023,0.0006088539,0.000420938,0.001230421,0.001266811,0.001599221,0.004572238],"category_scores_gemma":[0.001959613,0.0008967654,0.001855415,0.0005215731,0.001354351,0.00126073,0.0005602892,0.003032419,0.000779404],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009453425,"about_ca_system_score_gemma":0.001507878,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005633861,"about_ca_topic_score_gemma":0.001396747,"domain_scores_codex":[0.9989837,0.0006626253,0.00005046357,0.000135589,0.00006623911,0.000101347],"domain_scores_gemma":[0.9989485,0.0003010025,0.0002315086,0.00009679037,0.00004569289,0.0003765245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9463874,0.03084888,0.0009666018,0.0003380534,0.0006224623,0.0000702456,0.00005724395,0.000330271,0.004481075,0.00007942027,0.0004493646,0.01536915],"study_design_scores_gemma":[0.8820084,0.115693,0.001054349,0.00001300476,0.0001989457,0.00003941042,0.00001257928,0.0002953652,0.0003096006,0.00006385954,0.0003013361,0.00001016555],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924137,0.00225816,0.0005047631,0.0003875301,0.0002444924,0.002868228,0.0004795921,0.00007699202,0.0007665622],"genre_scores_gemma":[0.9866365,0.002566985,0.002042909,0.001124541,0.0006364965,0.004449125,0.001102517,0.00003163383,0.001409315],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004572238,"threshold_uncertainty_score":0.0171932,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152124092","doi":"10.1200/jco.2013.48.7934","title":"International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation","year":2014,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":384,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Cilag; Onyx Pharmaceuticals; National University Health System; Nagoya City University; Gil Medical Center, Gachon University; Genentech; Sahlgrenska Universitetssjukhuset; Università degli Studi di Pavia; Keio University; Cedars-Sinai Medical Center; Weill Cornell Medical College; Abbott Laboratories; Queen Mary University of London; University of Pittsburgh; Ankara Universitesi; University of Arkansas for Medical Sciences; Array BioPharma; Tel Aviv University; Gachon University; York University; Northwestern University; Emory University; American Society of Clinical Oncology; Universität Wien; Celgene; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; National and Kapodistrian University of Athens; Karolinska Institutet; Memorial Sloan-Kettering Cancer Center; Bristol-Myers Squibb; Daiichi-Sankyo; Takeda Oncology; Massachusetts General Hospital; Sanofi; Amgen","keywords":"Medicine; Multiple myeloma; Intensive care medicine; Transplantation; Adverse effect; Lenalidomide; Disease; Anemia; Autologous stem-cell transplantation; Concomitant; Internal medicine; Surgery","authors":[{"name":"Antonio Palumbo","is_ca":false},{"name":"S. Vincent Rajkumar","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false},{"name":"Alessandra Larocca","is_ca":false},{"name":"Rubén Niesvizky","is_ca":false},{"name":"Gareth J. Morgan","is_ca":false},{"name":"Ola Landgren","is_ca":false},{"name":"Roman Hájek","is_ca":false},{"name":"Hermann Einsele","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Paul G. Richardson","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Andrew Spencer","is_ca":false},{"name":"A. Keith Stewart","is_ca":false},{"name":"Kazuyuki Shimizu","is_ca":false},{"name":"Sagar Lonial","is_ca":false},{"name":"Pieter Sonneveld","is_ca":false},{"name":"Brian G.M. Durie","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1340411982215561,"gpt":0.4758519201022766,"spread":0.3418107218807206,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00955902,0.001311322,0.002968763,0.004477034,0.000962527,0.001331811,0.003728564,0.003276366,0.002368982],"category_scores_gemma":[0.00899299,0.000463402,0.002120205,0.003713738,0.0007873969,0.001358197,0.001715179,0.003842314,0.001899585],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002653971,"about_ca_system_score_gemma":0.01841889,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007874009,"about_ca_topic_score_gemma":0.008372619,"domain_scores_codex":[0.9970472,0.0007575096,0.0007697088,0.0001444572,0.001101755,0.0001792275],"domain_scores_gemma":[0.9925989,0.001656161,0.00122906,0.0001365743,0.003853183,0.0005261258],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001220546,0.0001513922,0.001182243,0.02281954,0.0003237461,0.0003021822,0.0001747024,0.0006209216,0.0006735838,0.003568839,0.3350431,0.6350178],"study_design_scores_gemma":[0.0001233736,0.0001125575,0.003184842,0.03595866,0.0007226879,0.001485644,0.0002742691,0.0002526685,0.0004903295,0.003354576,0.95399,0.00005034005],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005740709,0.9470447,0.002605038,0.03536496,0.006169379,0.0004352368,0.0008761492,0.00008968131,0.006840814],"genre_scores_gemma":[0.003416237,0.9619495,0.01516435,0.01128949,0.002191956,0.0006396699,0.002495634,0.00002955777,0.002823551],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00955902,"threshold_uncertainty_score":0.05055356,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2012182672","doi":"10.1016/j.ccr.2008.01.007","title":"AID-Dependent Activation of a MYC Transgene Induces Multiple Myeloma in a Conditional Mouse Model of Post-Germinal Center Malignancies","year":2008,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":383,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Cancer Institute; National Institute on Aging; National Institutes of Health; Multiple Myeloma Research Foundation","keywords":"Germinal center; Transgene; Multiple myeloma; Cancer research; Genetically modified mouse; Biology; Center (category theory); Genetics; Immunology; Gene; B cell; Chemistry; Antibody","authors":[{"name":"Marta Chesi","is_ca":false},{"name":"Davide F. Robbiani","is_ca":false},{"name":"Michaël Sébag","is_ca":false},{"name":"Wee Joo Chng","is_ca":false},{"name":"Maurizio Affer","is_ca":false},{"name":"Rodger E. Tiedemann","is_ca":false},{"name":"Riccardo Valdez","is_ca":false},{"name":"Stephen Palmer","is_ca":false},{"name":"Stephanie S. Haas","is_ca":false},{"name":"A. Keith Stewart","is_ca":false},{"name":"Rafaël Fonseca","is_ca":false},{"name":"Richard Kremer","is_ca":true},{"name":"Giorgio Cattoretti","is_ca":false},{"name":"P. Leif Bergsagel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05248662879118331,"gpt":0.2977271731314316,"spread":0.2452405443402483,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000569629,0.001041457,0.0005631123,0.001958806,0.0005137763,0.0009290507,0.000939781,0.001116966,0.003888059],"category_scores_gemma":[0.0002814219,0.0006855243,0.0006187382,0.0005510293,0.001124162,0.000634098,0.0006719233,0.003050606,0.001131661],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008985209,"about_ca_system_score_gemma":0.0004346537,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008716584,"about_ca_topic_score_gemma":0.001789341,"domain_scores_codex":[0.9992889,0.0001108531,0.00008918084,0.0001497686,0.000215091,0.0001461275],"domain_scores_gemma":[0.9991786,0.0001653882,0.0002581833,0.0001138859,0.00004354078,0.0002402564],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002849832,0.0001149275,0.0002087966,0.00003918606,0.00001305701,0.0002254157,0.00002705372,0.0001499907,0.9966239,0.001372652,0.0001294543,0.0008105565],"study_design_scores_gemma":[0.00007472175,0.0002207963,0.00104193,0.00001006116,0.00003302825,0.0006528417,0.00003895815,0.001593537,0.9930323,0.0001735567,0.003119562,0.000008742404],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9782347,0.001315069,0.01197431,0.0005606802,0.0001943501,0.0001969176,0.002239153,0.0008088932,0.004475866],"genre_scores_gemma":[0.9822314,0.0005613607,0.006015247,0.0001029242,0.00003947145,0.0001175424,0.0008514292,0.0002271988,0.009853438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003888059,"threshold_uncertainty_score":0.01300687,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3170038569","doi":"10.1016/s0140-6736(21)00592-4","title":"Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":380,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"Sanofi Genzyme; Sanofi","keywords":"Carfilzomib; Medicine; Dexamethasone; Multiple myeloma; Internal medicine; Population; Oncology; Lenalidomide","authors":[{"name":"Philippe Moreau","is_ca":true},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Joseph Mıkhael","is_ca":false},{"name":"Kwee Yong","is_ca":false},{"name":"Marcelo Capra","is_ca":false},{"name":"Thierry Façon","is_ca":false},{"name":"Roman Hájek","is_ca":false},{"name":"Ivan Špıčka","is_ca":false},{"name":"Ross Baker","is_ca":false},{"name":"Kihyun Kım","is_ca":false},{"name":"Gracia Martınez","is_ca":false},{"name":"Chang‐Ki Min","is_ca":false},{"name":"Luděk Pour","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Youngil Koh","is_ca":false},{"name":"Kenshi Suzuki","is_ca":false},{"name":"Marie‐Laure Risse","is_ca":false},{"name":"Gaëlle Asset","is_ca":false},{"name":"Sandrine Macé","is_ca":false},{"name":"Thomas G. Martin","is_ca":false},{"name":"Min Chang‐Ki","is_ca":false},{"name":"Tom Martin","is_ca":false},{"name":"Hang Quach","is_ca":false},{"name":"Andrew Lim","is_ca":false},{"name":"Helen Crowther","is_ca":false},{"name":"Hanlon Sia","is_ca":false},{"name":"Cyrille Hulin","is_ca":false},{"name":"Mohamad Mohty","is_ca":false},{"name":"Gábor Mikala","is_ca":false},{"name":"Zsolt Nagy","is_ca":false},{"name":"Marta Reinoso Segura","is_ca":false},{"name":"Laura Rosiñol","is_ca":false},{"name":"Münci Yağcı","is_ca":false},{"name":"Mehmet Turgut","is_ca":false},{"name":"Mamta Garg","is_ca":false},{"name":"Gurdeep Parmar","is_ca":false},{"name":"Brad Augustson","is_ca":false},{"name":"Nelson Castro","is_ca":false},{"name":"Edvan de Queiroz Crusoé","is_ca":false},{"name":"Tomáš Pika","is_ca":false},{"name":"Sosana Delimpasi","is_ca":false},{"name":"Kenichi Ishizawa","is_ca":false},{"name":"Anup George","is_ca":false},{"name":"Т. С. Константинова","is_ca":false},{"name":"Javier de la Rubia","is_ca":false},{"name":"Kim Sung-Hyun","is_ca":false},{"name":"Ângelo Maiolino","is_ca":false},{"name":"Tony Reiman","is_ca":false},{"name":"Richard LeBlanc","is_ca":false},{"name":"Shigeki Ito","is_ca":false},{"name":"Junji Tanaka","is_ca":false},{"name":"А. С. Лучинин","is_ca":false},{"name":"I. V. Kryuchkova","is_ca":false},{"name":"Joaquín Martínez‐López","is_ca":false},{"name":"Jesse Shustik","is_ca":false},{"name":"Lionel Karlin","is_ca":false},{"name":"Miklós Egyed","is_ca":false},{"name":"Mario Petrini","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Michihiro Uchiyama","is_ca":false},{"name":"Hilary Blacklock","is_ca":false},{"name":"Mutlu Arat","is_ca":false},{"name":"James E. Griffin","is_ca":false},{"name":"Hannah Hunter","is_ca":false},{"name":"Tonda Buck","is_ca":false},{"name":"Αchilles Anagnostopoulos","is_ca":false},{"name":"Κωνσταντίνος Κωνσταντόπουλος","is_ca":false},{"name":"Tamás Masszi","is_ca":false},{"name":"Sara Bringhen","is_ca":false},{"name":"Barbara Gamberi","is_ca":false},{"name":"Yawara Kawano","is_ca":false},{"name":"Kim Jin Seok","is_ca":false},{"name":"Hakan Özdoğu","is_ca":false},{"name":"Fahir Özkalemkaş","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1055133731748032,"gpt":0.388914458078011,"spread":0.2834010849032078,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002204221,0.001980276,0.004027249,0.000365003,0.0004524103,0.001433719,0.0009846884,0.002033833,0.007155163],"category_scores_gemma":[0.001620054,0.0006205163,0.00281166,0.0005615425,0.001273899,0.001132764,0.0005993033,0.004264979,0.00117704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001066522,"about_ca_system_score_gemma":0.001184577,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001621664,"about_ca_topic_score_gemma":0.003140687,"domain_scores_codex":[0.9992321,0.0003807716,0.00003403725,0.0001240319,0.0000532375,0.0001758899],"domain_scores_gemma":[0.9990667,0.0002913429,0.0002005444,0.00007061521,0.00004707057,0.000323754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9840492,0.001654704,0.0003636566,0.000592781,0.0009889458,0.00002878202,0.00003272372,0.0002386802,0.000971677,0.00009190119,0.0008217315,0.01016533],"study_design_scores_gemma":[0.9747998,0.02289455,0.001045515,0.00003677545,0.0003969262,0.00002868446,0.00001777017,0.0001346403,0.00008704263,0.000113658,0.0004341521,0.00001050987],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9656377,0.02280273,0.0006890437,0.002073312,0.001385501,0.002904648,0.001593285,0.0001691124,0.002744631],"genre_scores_gemma":[0.9804147,0.007241882,0.001390798,0.002216059,0.0007683274,0.0027978,0.001529812,0.0000296163,0.003610913],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007155163,"threshold_uncertainty_score":0.02393639,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2015003025","doi":"10.1038/leu.2009.26","title":"Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":371,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Dexamethasone; Cyclophosphamide; Bortezomib; Multiple myeloma; Autologous stem-cell transplantation; Internal medicine; Gastroenterology; Surgery; Toxicity; Phases of clinical research; Chemotherapy","authors":[{"name":"Craig B. Reeder","is_ca":false},{"name":"Donna Reece","is_ca":true},{"name":"Vishal Kukreti","is_ca":true},{"name":"Christine Chen","is_ca":true},{"name":"Suzanne Trudel","is_ca":true},{"name":"Joseph G. Hentz","is_ca":false},{"name":"Brie N. Noble","is_ca":false},{"name":"Nicholas Pirooz","is_ca":false},{"name":"Jacy Spong","is_ca":false},{"name":"J Píza","is_ca":true},{"name":"Victor H Jimenez Zepeda","is_ca":false},{"name":"Joseph Mıkhael","is_ca":false},{"name":"José F. Leis","is_ca":false},{"name":"P. Leif Bergsagel","is_ca":false},{"name":"Rafaël Fonseca","is_ca":false},{"name":"A. Keith Stewart","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06004671005117541,"gpt":0.3975095953405324,"spread":0.337462885289357,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003452785,0.001594594,0.00380937,0.0005328963,0.0005473293,0.001327769,0.001020745,0.001693323,0.003301446],"category_scores_gemma":[0.002158273,0.0005784472,0.001850309,0.0007717344,0.001202007,0.00105471,0.0004451537,0.004122678,0.0007429707],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001268428,"about_ca_system_score_gemma":0.001843594,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000960589,"about_ca_topic_score_gemma":0.002414827,"domain_scores_codex":[0.9988376,0.000695459,0.00006006949,0.0001544005,0.00007919688,0.0001733371],"domain_scores_gemma":[0.9980425,0.0006846321,0.0003147779,0.0001757649,0.00006775153,0.0007145888],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9027339,0.02111565,0.002263769,0.0004789696,0.001273708,0.0001351337,0.0001251932,0.0009640111,0.008276813,0.0001359681,0.001969206,0.06052765],"study_design_scores_gemma":[0.8703552,0.1220758,0.004519347,0.00002913568,0.0004322506,0.0001226513,0.00002194646,0.0002889032,0.0009042038,0.00009727994,0.001135505,0.00001771886],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871793,0.006164177,0.0005767659,0.001115752,0.0003244101,0.001853777,0.001010668,0.0001116323,0.001663442],"genre_scores_gemma":[0.9873881,0.004027641,0.001558957,0.001322651,0.0004273009,0.001746357,0.001442018,0.00004817011,0.002038728],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00380937,"threshold_uncertainty_score":0.01826024,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122021478","doi":"10.1182/blood-2005-09-3869","title":"Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":370,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Hospital","funders":"","keywords":"Medicine; Melphalan; Transplantation; Autologous stem-cell transplantation; Multiple myeloma; Surgery; Internal medicine; Regimen; Vincristine; Clinical trial; Stem cell; Cyclophosphamide; Chemotherapy; Biology","authors":[{"name":"Frédéric Garban","is_ca":true},{"name":"Michel Attal","is_ca":true},{"name":"Mauricette Michallet","is_ca":true},{"name":"Cyrille Hulin","is_ca":true},{"name":"Jean Henri Bourhis","is_ca":true},{"name":"Ibrahim Yakoub‐Agha","is_ca":true},{"name":"Thierry Lamy","is_ca":true},{"name":"Gérald Marit","is_ca":true},{"name":"Frédéric Maloisel","is_ca":true},{"name":"Christian Berthou","is_ca":true},{"name":"Mamoun Dib","is_ca":true},{"name":"Denis Caillot","is_ca":true},{"name":"Bernard Deprijck","is_ca":true},{"name":"Nicolas Ketterer","is_ca":true},{"name":"Jean‐Luc Harousseau","is_ca":true},{"name":"Jean‐Jacques Sotto","is_ca":true},{"name":"Philippe Moreau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01540223359039853,"gpt":0.2671610918165032,"spread":0.2517588582261046,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002289382,0.0007693971,0.001620041,0.0003386267,0.0002193726,0.0009446235,0.0009655746,0.00136517,0.001883578],"category_scores_gemma":[0.001356176,0.0002510422,0.001457789,0.0003660264,0.0007346866,0.0006042951,0.0004203283,0.002052391,0.0003824264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007481684,"about_ca_system_score_gemma":0.0007141227,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004114292,"about_ca_topic_score_gemma":0.000958516,"domain_scores_codex":[0.9990872,0.0005990007,0.00004790985,0.00009834897,0.00005630127,0.0001112692],"domain_scores_gemma":[0.9990662,0.0002440638,0.0002629095,0.00009706791,0.00003323971,0.0002965433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9664564,0.004897647,0.00419448,0.0001585283,0.0006727631,0.00005443003,0.0000380513,0.0005379054,0.001943235,0.0001829327,0.0004118067,0.02045193],"study_design_scores_gemma":[0.6098997,0.363699,0.01959651,0.00010151,0.00124128,0.0002294922,0.0000540424,0.001296058,0.00129441,0.0005790977,0.001981195,0.00002773163],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951101,0.00287942,0.0001616093,0.0002303247,0.0001142345,0.0003729857,0.0001381937,0.00001613119,0.0009769591],"genre_scores_gemma":[0.9952574,0.001327884,0.000580092,0.0006076014,0.000225096,0.0006032469,0.0005647959,0.000008746614,0.0008250603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002289382,"threshold_uncertainty_score":0.01210755,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3206192616","doi":"10.1016/s1470-2045(21)00466-6","title":"Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":363,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research; University of Alberta; University of Calgary","funders":"Janssen Research and Development; Strong","keywords":"Lenalidomide; Daratumumab; Dexamethasone; Medicine; Multiple myeloma; Open label; Oncology; Internal medicine; Clinical trial","authors":[{"name":"Thierry Façon","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Torben Plesner","is_ca":false},{"name":"Robert Z. Orlowski","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Supratik Basu","is_ca":false},{"name":"Hareth Nahi","is_ca":false},{"name":"Cyrille Hulin","is_ca":false},{"name":"Hang Quach","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Michael O’Dwyer","is_ca":false},{"name":"Aurore Perrot","is_ca":false},{"name":"Christopher P. Venner","is_ca":true},{"name":"Katja Weisel","is_ca":false},{"name":"Joseph R. Mace","is_ca":false},{"name":"Noopur Raje","is_ca":false},{"name":"Mourad Tiab","is_ca":false},{"name":"Margaret Macro","is_ca":false},{"name":"Laurent Frenzel","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Tahamtan Ahmadi","is_ca":false},{"name":"Jianping Wang","is_ca":false},{"name":"Rian Van Rampelbergh","is_ca":false},{"name":"Clarissa Uhlar","is_ca":false},{"name":"Brenda Tromp","is_ca":false},{"name":"Maria Delioukina","is_ca":false},{"name":"Jessica Vermeulen","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1690328158794252,"gpt":0.4209981267549274,"spread":0.2519653108755022,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002430832,0.002142257,0.003841593,0.0004215793,0.0005365629,0.001577853,0.001136384,0.001991204,0.005030712],"category_scores_gemma":[0.002461625,0.000684727,0.004107087,0.0005003905,0.001505369,0.001602548,0.0007003566,0.004887861,0.0009817249],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001236375,"about_ca_system_score_gemma":0.001103701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001404993,"about_ca_topic_score_gemma":0.003080264,"domain_scores_codex":[0.9991388,0.0004741235,0.00004952779,0.0001545356,0.00005316324,0.0001298432],"domain_scores_gemma":[0.9982294,0.0007116284,0.0003848713,0.000106415,0.0000669768,0.000500686],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.985514,0.002152792,0.000374124,0.0004081751,0.001167353,0.00002327454,0.00004234125,0.0002421864,0.0008245286,0.00005843712,0.0004284533,0.008764372],"study_design_scores_gemma":[0.9618001,0.03535942,0.001301879,0.00004056265,0.0006203493,0.00003432558,0.00002520151,0.000170294,0.0001303619,0.0001602585,0.0003454549,0.0000117811],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9802243,0.01321002,0.0004065175,0.001206207,0.0008835547,0.001395012,0.001035356,0.00009469323,0.00154453],"genre_scores_gemma":[0.9859029,0.005120836,0.001185891,0.001420163,0.0006784432,0.001814517,0.001140246,0.00002757518,0.002709437],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005030712,"threshold_uncertainty_score":0.01682943,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2000069677","doi":"10.1038/leu.2009.147","title":"Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma","year":2009,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Lenalidomide; Dexamethasone; Medicine; Placebo; Multiple myeloma; Internal medicine; Gastroenterology; Refractory (planetary science); Phases of clinical research; Surgery; Clinical trial; Pathology","authors":[{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Christine Chen","is_ca":true},{"name":"Andrew Spencer","is_ca":false},{"name":"Rubén Niesvizky","is_ca":false},{"name":"Michel Attal","is_ca":false},{"name":"Edward A. Stadtmauer","is_ca":false},{"name":"Maria Teresa Petrucci","is_ca":false},{"name":"Zhinuan Yu","is_ca":false},{"name":"Marta Olesnyckyj","is_ca":false},{"name":"Jerome B. Zeldis","is_ca":false},{"name":"Robert Knight","is_ca":false},{"name":"D. Weber","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04957727320909769,"gpt":0.3301043192462646,"spread":0.2805270460371669,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004036549,0.0006581584,0.002062981,0.0005189363,0.0007948781,0.001473389,0.0007900982,0.001210548,0.002248392],"category_scores_gemma":[0.004171522,0.000271272,0.002910607,0.0008691135,0.0005012715,0.001469715,0.0009809443,0.002844056,0.0003843655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001132791,"about_ca_system_score_gemma":0.001252609,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003700142,"about_ca_topic_score_gemma":0.007564011,"domain_scores_codex":[0.998903,0.0003825288,0.0001059899,0.0001409055,0.0001427743,0.0003247204],"domain_scores_gemma":[0.9953598,0.001509804,0.00107723,0.0002940069,0.0002936574,0.001465417],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4778909,0.0037016,0.3399016,0.001054924,0.01023468,0.0007105998,0.0005495542,0.004798738,0.004584056,0.0003612144,0.01024911,0.1459631],"study_design_scores_gemma":[0.02461563,0.05719557,0.8958451,0.0002746194,0.01159043,0.0006291762,0.0003472028,0.001133585,0.0009124521,0.00051768,0.006833634,0.0001049859],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9760218,0.01570639,0.0002751873,0.00106171,0.0001398548,0.0001054465,0.004168672,0.00002601524,0.00249475],"genre_scores_gemma":[0.9883267,0.002554195,0.0001098616,0.001005992,0.0001832099,0.00008281152,0.006566819,0.0000128957,0.001157388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004036549,"threshold_uncertainty_score":0.02134752,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2100738529","doi":"10.1200/jco.2012.47.7901","title":"International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":355,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Nutrition, Metabolism and Diabetes","funders":"Cilag; Celgene; Takeda Oncology; Onyx Pharmaceuticals; Pfizer; Amgen","keywords":"Medicine; Multiple myeloma; Zoledronic acid; Spinal cord compression; Bone disease; Magnetic resonance imaging; Disease; Radiography; Radiology; Bisphosphonate; Surgery; Internal medicine; Osteoporosis; Spinal cord","authors":[{"name":"Evangelos Terpos","is_ca":false},{"name":"Gareth J. Morgan","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Matthew T. Drake","is_ca":true},{"name":"Suzanne Lentzsch","is_ca":false},{"name":"Noopur Raje","is_ca":false},{"name":"Orhan Sezer","is_ca":false},{"name":"Ramón García‐Sánz","is_ca":false},{"name":"Kazuyuki Shimizu","is_ca":false},{"name":"Ingemar Turesson","is_ca":false},{"name":"Tony Reiman","is_ca":false},{"name":"Artur Jurczyszyn","is_ca":false},{"name":"Giampaolo Merlini","is_ca":false},{"name":"Andrew Spencer","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Nikhil C. Munshi","is_ca":false},{"name":"S. Vincent Rajkumar","is_ca":false},{"name":"Brian G.M. Durie","is_ca":false},{"name":"G. David Roodman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1831751629649877,"gpt":0.4766221856333922,"spread":0.2934470226684045,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03096763,0.001834901,0.002645607,0.008213001,0.001750211,0.004109914,0.008845306,0.009106457,0.01221384],"category_scores_gemma":[0.06736487,0.001210647,0.00519824,0.005481829,0.001436624,0.002877145,0.003806153,0.01242036,0.009734693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007649293,"about_ca_system_score_gemma":0.03472135,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02495654,"about_ca_topic_score_gemma":0.01646777,"domain_scores_codex":[0.9655089,0.01279378,0.007294746,0.001149496,0.01175568,0.001497304],"domain_scores_gemma":[0.9224371,0.0123044,0.009978869,0.001610426,0.05035861,0.003310703],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001137412,0.0001671953,0.001375456,0.005082233,0.0002204057,0.0001503327,0.0002109968,0.0005695958,0.0002578082,0.00372938,0.8364166,0.1517062],"study_design_scores_gemma":[0.0003314249,0.000112212,0.003304912,0.01880546,0.0003808683,0.0004048127,0.0002265939,0.0004290084,0.0002156065,0.005534448,0.9701933,0.00006130321],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.002411765,0.2821948,0.03142833,0.487554,0.04588848,0.0126397,0.01453598,0.001340653,0.1220063],"genre_scores_gemma":[0.0242465,0.3425331,0.272221,0.1968992,0.0174052,0.02249694,0.05945846,0.0007401739,0.06399935],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.03096763,"threshold_uncertainty_score":0.1637744,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2625253716","doi":"10.1038/leu.2017.138","title":"Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study","year":2017,"lang":"en","type":"article","venue":"Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":354,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; McGill University Health Centre","funders":"Janssen Pharmaceuticals","keywords":"Multiple myeloma; Medicine; Internal medicine; Carfilzomib; Oncology; Proteasome inhibitor; Lenalidomide; Refractory (planetary science); Hematology; Natural history; Pomalidomide; Bortezomib; Biology","authors":[{"name":"Shaji Kumar","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Efstathios Kastritis","is_ca":false},{"name":"Evangelos Terpos","is_ca":false},{"name":"Hareth Nahi","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Jens Hillengaß","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Meral Beksaç","is_ca":false},{"name":"Melissa Alsina","is_ca":false},{"name":"Albert Oriol","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Enrique M. Ocio","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Elizabeth O’Donnell","is_ca":false},{"name":"Ravi Vij","is_ca":false},{"name":"H M Lokhorst","is_ca":false},{"name":"Niels W.C.J. van de Donk","is_ca":false},{"name":"Chang‐Ki Min","is_ca":false},{"name":"Tomer M. Mark","is_ca":false},{"name":"Ingemar Turesson","is_ca":false},{"name":"Markus Hansson","is_ca":false},{"name":"Heinz Ludwig","is_ca":false},{"name":"Sundar Jagannath","is_ca":false},{"name":"Michel Delforge","is_ca":false},{"name":"Charalampia Kyriakou","is_ca":false},{"name":"Parameswaran Hari","is_ca":false},{"name":"Ulf‐Henrik Mellqvist","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false},{"name":"Dominik Dytfeld","is_ca":false},{"name":"Ashraf Badros","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"K Kim","is_ca":false},{"name":"J H Lee","is_ca":false},{"name":"Chaim Shustik","is_ca":true},{"name":"Daniel D. Waller","is_ca":true},{"name":"Wee Joo Chng","is_ca":false},{"name":"Shuji Ozaki","is_ca":false},{"name":"Javier de la Rubia","is_ca":false},{"name":"Hyeon‐Seok Eom","is_ca":false},{"name":"Laura Rosiñol","is_ca":false},{"name":"Juan José Lahuerta","is_ca":false},{"name":"Anna Sureda","is_ca":false},{"name":"Jin Seok Kim","is_ca":false},{"name":"B G M Durie","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01825545139266853,"gpt":0.293698689027516,"spread":0.2754432376348475,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001338981,0.0007200821,0.0009934983,0.0006274896,0.0006989065,0.0009156317,0.0007687939,0.0008660401,0.0009877976],"category_scores_gemma":[0.001334651,0.0004069034,0.0007283863,0.001123616,0.0005417214,0.001151563,0.000696369,0.0008122142,0.0003292864],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007755916,"about_ca_system_score_gemma":0.0005236489,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001512976,"about_ca_topic_score_gemma":0.001310011,"domain_scores_codex":[0.9992996,0.0002334304,0.00004794225,0.0002209023,0.00006028711,0.0001378347],"domain_scores_gemma":[0.9989078,0.0001076282,0.0003881646,0.000147107,0.00007619731,0.0003730647],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01123436,0.0007987191,0.9797561,0.00003345764,0.0003629967,0.0003641598,0.0002739149,0.0001429663,0.001546997,0.00005108044,0.000394479,0.005040757],"study_design_scores_gemma":[0.0008429508,0.003148291,0.9934209,0.00001295307,0.0003173709,0.0007657622,0.0002842448,0.0002880183,0.0002133181,0.00006865545,0.000621161,0.00001649425],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991791,0.000274712,0.00003468397,0.00003072718,0.000002883045,0.00002398512,0.0002689252,0.000003502987,0.0001815124],"genre_scores_gemma":[0.9986884,0.0001056892,0.00006476364,0.00006676131,0.00002451637,0.00003367236,0.0008357497,0.000004509851,0.0001759092],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001512976,"threshold_uncertainty_score":0.00708133,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2928272073","doi":"10.1200/jco.18.02096","title":"Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":333,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster University; Princess Margaret Cancer Centre; Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Guideline; Multiple myeloma; Randomized controlled trial; Evidence-based medicine; Systematic review; MEDLINE; Intensive care medicine; Evidence-based practice; Family medicine; Quality of life (healthcare); Clinical trial; Oncology; Internal medicine; Alternative medicine; Nursing; Pathology","authors":[{"name":"Joseph Mıkhael","is_ca":false},{"name":"Nofisat Ismaila","is_ca":false},{"name":"Matthew C. Cheung","is_ca":true},{"name":"Caitlin Costello","is_ca":false},{"name":"Madhav V. Dhodapkar","is_ca":false},{"name":"Shaji Kumar","is_ca":false},{"name":"Martha Q. Lacy","is_ca":false},{"name":"Brea Lipe","is_ca":false},{"name":"Richard F. Little","is_ca":false},{"name":"Anna S. Nikonova","is_ca":true},{"name":"James Omel","is_ca":false},{"name":"Namrata Peswani","is_ca":false},{"name":"Anca Prica","is_ca":true},{"name":"Noopur Raje","is_ca":false},{"name":"Rahul Seth","is_ca":false},{"name":"David H. Vesole","is_ca":false},{"name":"Irwin Walker","is_ca":true},{"name":"Alexander C. Whitley","is_ca":false},{"name":"Tanya M. Wildes","is_ca":false},{"name":"Sandy W. Wong","is_ca":false},{"name":"Tom Martin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2089278753004978,"gpt":0.5413060471164012,"spread":0.3323781718159034,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0136958,0.002042709,0.003870231,0.006903181,0.00246674,0.003242505,0.007583282,0.01102318,0.006142422],"category_scores_gemma":[0.04426364,0.00123696,0.005756561,0.006448444,0.001563562,0.002649267,0.00350569,0.010317,0.004073872],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009497494,"about_ca_system_score_gemma":0.04232386,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.05393193,"about_ca_topic_score_gemma":0.08622628,"domain_scores_codex":[0.9844607,0.004781005,0.004818057,0.0007566015,0.004345307,0.0008384273],"domain_scores_gemma":[0.9632688,0.007676424,0.005586244,0.0006976511,0.02002416,0.002746739],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001179213,0.0002042936,0.001953355,0.02118176,0.0006173034,0.0003974354,0.0003816965,0.001106931,0.000495234,0.0033473,0.8305035,0.1396934],"study_design_scores_gemma":[0.001064503,0.0001706395,0.00853413,0.1628293,0.002854281,0.001093962,0.0005490977,0.001685258,0.000649082,0.01196812,0.8084058,0.0001959167],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.004160653,0.3031952,0.02752701,0.533219,0.02754074,0.01408217,0.01781681,0.001160761,0.07129772],"genre_scores_gemma":[0.03443067,0.3848038,0.2781869,0.206175,0.0134573,0.01913215,0.03466383,0.0004519345,0.02869852],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.05393193,"threshold_uncertainty_score":0.107236,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3105812043","doi":"10.1016/s0140-6736(20)32292-3","title":"Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Dalhousie University; University of Alberta; Queen Elizabeth II Health Sciences Centre; Institute of Cancer Research; University of Calgary","funders":"Cancer Research UK","keywords":"Bortezomib; Dexamethasone; Medicine; Multiple myeloma; Proteasome inhibitor; Clinical endpoint; Internal medicine; Population; Clinical trial; Oncology","authors":[{"name":"Sebastian Grosicki","is_ca":false},{"name":"Maryana Simonova","is_ca":false},{"name":"Ivan Špıčka","is_ca":false},{"name":"Luděk Pour","is_ca":false},{"name":"Iryrna Kriachok","is_ca":false},{"name":"Maria Gavriatopoulou","is_ca":false},{"name":"Halyna Pylypenko","is_ca":false},{"name":"Holger W. Auner","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Vadim Doronin","is_ca":false},{"name":"Ganna Usenko","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Roman Hájek","is_ca":false},{"name":"Reuben Benjamin","is_ca":false},{"name":"Tuphan Kanti Dolai","is_ca":false},{"name":"Dinesh Kumar Sinha","is_ca":false},{"name":"Christopher P. Venner","is_ca":true},{"name":"Mamta Garg","is_ca":false},{"name":"Mercedes Gironella","is_ca":false},{"name":"Artur Jurczyszyn","is_ca":false},{"name":"Paweł Robak","is_ca":false},{"name":"Mónica Galli","is_ca":false},{"name":"Craig T. Wallington‐Beddoe","is_ca":false},{"name":"Atanas Radinoff","is_ca":false},{"name":"Galina Salogub","is_ca":false},{"name":"Don A. Stevens","is_ca":false},{"name":"Supratik Basu","is_ca":false},{"name":"Anna Marina Liberati","is_ca":false},{"name":"Hang Quach","is_ca":false},{"name":"Vesselina Goranova‐Marinova","is_ca":false},{"name":"Jelena Bila","is_ca":false},{"name":"Eirini Katodritou","is_ca":false},{"name":"Hanna Oliynyk","is_ca":false},{"name":"Sybiryna Korenkova","is_ca":false},{"name":"Jeevan Kumar","is_ca":false},{"name":"Sundar Jagannath","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Moshe Levy","is_ca":false},{"name":"Darrell White","is_ca":true},{"name":"Moshe E. Gatt","is_ca":false},{"name":"Thierry Façon","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Donna Reece","is_ca":true},{"name":"Larry D. Anderson","is_ca":false},{"name":"Jean-Richard Saint-Martin","is_ca":false},{"name":"Jacqueline Jeha","is_ca":false},{"name":"Anita Joshi","is_ca":false},{"name":"Yi Chai","is_ca":false},{"name":"Lingling Li","is_ca":false},{"name":"Vishnuvardhan Peddagali","is_ca":false},{"name":"Melina Arazy","is_ca":false},{"name":"Jatin J. Shah","is_ca":false},{"name":"Sharon Shacham","is_ca":false},{"name":"Michael Kauffman","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Paul G. Richardson","is_ca":false},{"name":"Sosana Delimpasi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1084690263159896,"gpt":0.353852140548447,"spread":0.2453831142324574,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002372856,0.002815036,0.003990802,0.0005578897,0.0005408969,0.001502843,0.001251973,0.002827498,0.01105037],"category_scores_gemma":[0.002255514,0.0009991523,0.003289279,0.0005059507,0.001922734,0.001862206,0.0007216213,0.004703573,0.001731914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001229031,"about_ca_system_score_gemma":0.001194616,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002036768,"about_ca_topic_score_gemma":0.003854248,"domain_scores_codex":[0.9991373,0.000468984,0.00004152557,0.0001711732,0.00005059982,0.0001303355],"domain_scores_gemma":[0.9986057,0.0005219789,0.0002682032,0.00009363046,0.00005515486,0.0004554515],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9915616,0.001836411,0.0001569456,0.0002520138,0.0004732462,0.00001574497,0.00002973601,0.0001443897,0.0007171061,0.00005517123,0.0003725317,0.004385014],"study_design_scores_gemma":[0.9807327,0.0183042,0.0003795045,0.00001475551,0.0001373611,0.00001018062,0.00001276456,0.0001019402,0.00005767684,0.00007609946,0.0001653889,0.000007437728],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9791917,0.008899195,0.0007682894,0.002220703,0.001555494,0.003142067,0.001644026,0.0002001248,0.002378394],"genre_scores_gemma":[0.978912,0.004477125,0.001774844,0.002313095,0.0009067254,0.00379517,0.001385276,0.00005158916,0.006384208],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01105037,"threshold_uncertainty_score":0.03696716,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386324983","doi":"10.1038/s41591-023-02491-5","title":"Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma","year":2023,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":318,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"National Cancer Institute; Terry Fox Foundation; Glenmark Pharmaceuticals; University of Calgary; Comprehensive Cancer Center, City of Hope; Sylvester Comprehensive Cancer Center, University of Miami Health Systems; Celgene; Genentech; Deutsche Krebshilfe; Rising Tide Foundation; Pfizer; Amgen; Health Research Board; Multiple Myeloma Research Foundation","keywords":"Chimeric antigen receptor; Antigen; Cancer research; Multiple myeloma; Missense mutation; Immunology; Immunotherapy; Biology; Medicine; Mutation; Genetics; Gene; Immune system","authors":[{"name":"Holly Lee","is_ca":true},{"name":"Sungwoo Ahn","is_ca":true},{"name":"Ranjan Maity","is_ca":true},{"name":"Noémie Leblay","is_ca":true},{"name":"Bachisio Ziccheddu","is_ca":false},{"name":"Marietta Truger","is_ca":false},{"name":"Monika Chojnacka","is_ca":false},{"name":"Anthony Cirrincione","is_ca":false},{"name":"Michael Durante","is_ca":false},{"name":"Rémi Tilmont","is_ca":true},{"name":"Elie Barakat","is_ca":true},{"name":"Mansour Poorebrahim","is_ca":true},{"name":"Sarthak Sinha","is_ca":true},{"name":"John A. McIntyre","is_ca":false},{"name":"Angela Chan","is_ca":false},{"name":"Holly Wilson","is_ca":false},{"name":"Shari Kyman","is_ca":false},{"name":"Amrita Krishnan","is_ca":false},{"name":"Ola Landgren","is_ca":false},{"name":"Wencke Walter","is_ca":false},{"name":"Manja Meggendorfer","is_ca":false},{"name":"Claudia Haferlach","is_ca":false},{"name":"Torsten Haferlach","is_ca":false},{"name":"Hermann Einsele","is_ca":false},{"name":"K. Martin Kortüm","is_ca":false},{"name":"Stefan Knop","is_ca":false},{"name":"Jean Baptiste Alberge","is_ca":false},{"name":"Andreas Rosenwald","is_ca":false},{"name":"Jonathan J. Keats","is_ca":false},{"name":"Leo Rasche","is_ca":false},{"name":"Francesco Maura","is_ca":false},{"name":"Paola Neri","is_ca":true},{"name":"Nizar J. Bahlis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02830774918335869,"gpt":0.324962472355331,"spread":0.2966547231719723,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002245283,0.0001839783,0.0002552679,0.0004553239,0.0001497578,0.0003449849,0.0003104814,0.0004067239,0.0003254191],"category_scores_gemma":[0.000258895,0.0001324091,0.0002639664,0.0002900641,0.0002746198,0.0001806183,0.0003283885,0.0002200746,0.0001064601],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004326385,"about_ca_system_score_gemma":0.0001109183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004369262,"about_ca_topic_score_gemma":0.000383308,"domain_scores_codex":[0.9998523,0.00002425062,0.00001545428,0.0000341978,0.0000417458,0.00003202431],"domain_scores_gemma":[0.9999053,0.00001443787,0.00005172017,0.00001351525,0.000005047129,0.000009966658],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0009216625,0.0001346353,0.1404776,0.0001998159,0.0001180247,0.008798478,0.000468504,0.001358544,0.7910514,0.001055231,0.0002287865,0.05518721],"study_design_scores_gemma":[0.0001012028,0.001470877,0.6491271,0.00003210324,0.0002365148,0.07764769,0.0003346196,0.007830899,0.2574236,0.00111573,0.004645879,0.00003381909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977375,0.001332073,0.0005173693,0.00002444067,0.000001048339,0.000008831637,0.0000270753,0.00001992459,0.0003317466],"genre_scores_gemma":[0.9993555,0.0002685042,0.0002012429,0.00001775003,0.000002108093,0.00000442453,0.00004007947,0.000002306344,0.0001080175],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0004553239,"threshold_uncertainty_score":0.003139019,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2291176625","doi":"10.1158/1535-7163.mct-15-0730","title":"Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models","year":2016,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":309,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Discovery Centre","funders":"","keywords":"Venetoclax; Multiple myeloma; Bortezomib; Cancer research; Bcl-xL; Lenalidomide; Medicine; Pharmacology; Biology; Leukemia; Apoptosis; Immunology; Programmed cell death; Chronic lymphocytic leukemia; Genetics","authors":[{"name":"Elizabeth A. Punnoose","is_ca":false},{"name":"Joel D. Leverson","is_ca":false},{"name":"Franklin Peale","is_ca":false},{"name":"Erwin R. Boghaert","is_ca":false},{"name":"Lisa D. Belmont","is_ca":false},{"name":"Nguyen Tan","is_ca":false},{"name":"A. Young","is_ca":false},{"name":"Michael J. Mitten","is_ca":false},{"name":"Ellen Ingalla","is_ca":false},{"name":"Walter C. Darbonne","is_ca":false},{"name":"Anatol Oleksijew","is_ca":false},{"name":"Paul Tapang","is_ca":false},{"name":"Yue Peng","is_ca":false},{"name":"Jason Oeh","is_ca":false},{"name":"Leslie Lee","is_ca":false},{"name":"Sophie Maïga","is_ca":false},{"name":"Wayne J. Fairbrother","is_ca":true},{"name":"Martine Amiot","is_ca":false},{"name":"Andrew J. Souers","is_ca":false},{"name":"Deepak Sampath","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05085372977947655,"gpt":0.3446252469714147,"spread":0.2937715171919382,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001255894,0.0001551475,0.0002402657,0.0003053414,0.0001727869,0.0003169641,0.0001296771,0.0002421008,0.001299641],"category_scores_gemma":[0.0001337781,0.0001447935,0.0001482795,0.000292922,0.0001389805,0.0001923665,0.0001051296,0.000781164,0.0002258481],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003461606,"about_ca_system_score_gemma":0.0001460422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000895858,"about_ca_topic_score_gemma":0.001439194,"domain_scores_codex":[0.9998784,0.00001251829,0.000007696979,0.00002313025,0.00003575891,0.00004237758],"domain_scores_gemma":[0.999907,0.00001295439,0.00002616293,0.000007212062,0.00001203858,0.00003461684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003846111,0.00009940216,0.001468083,0.00001180677,0.000006079865,0.00001599608,0.00001551223,0.00009156841,0.9967747,0.00002653224,0.00003904259,0.001066626],"study_design_scores_gemma":[0.00005106391,0.002170225,0.04325669,0.000005522649,0.00004584049,0.0004522254,0.0000694536,0.003195253,0.9493039,0.00005249006,0.001387785,0.000009622169],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974087,0.0008281919,0.0007934115,0.00003196527,0.000008000316,0.00001936731,0.0002417162,0.00004028154,0.0006283867],"genre_scores_gemma":[0.9974908,0.0003888676,0.0007324903,0.00001822267,0.000003599567,0.00002525936,0.0003740943,0.000005642708,0.0009611316],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001299641,"threshold_uncertainty_score":0.004347742,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1989740966","doi":"10.1111/j.1365-2141.2008.07573.x","title":"Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose‐modification guideline","year":2009,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":308,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Takeda Oncology","keywords":"Medicine; Bortezomib; Peripheral neuropathy; Multiple myeloma; Internal medicine; Guideline; Surgery; Gastroenterology; Oncology; Diabetes mellitus; Pathology; Endocrinology","authors":[{"name":"Paul G. Richardson","is_ca":false},{"name":"Pieter Sonneveld","is_ca":false},{"name":"Michael W. Schuster","is_ca":false},{"name":"Edward A. Stadtmauer","is_ca":false},{"name":"Thierry Façon","is_ca":false},{"name":"Jean‐Luc Harousseau","is_ca":false},{"name":"Dina Ben‐Yehuda","is_ca":false},{"name":"Sagar Lonial","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Donna Reece","is_ca":true},{"name":"Joan Bladé","is_ca":false},{"name":"Mario Boccadoro","is_ca":false},{"name":"Jamie Cavenagh","is_ca":false},{"name":"Anthony Boral","is_ca":false},{"name":"Dixie‐Lee Esseltine","is_ca":false},{"name":"Patrick Y. Wen","is_ca":false},{"name":"Anthony A. Amato","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03042436538693536,"gpt":0.361632983993509,"spread":0.3312086186065736,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006722196,0.0003365013,0.001869348,0.0001515226,0.0002362867,0.0009830212,0.0006032199,0.0007227062,0.0007475943],"category_scores_gemma":[0.00360863,0.0001878259,0.00132858,0.0003318451,0.0003753704,0.0004561259,0.0002684777,0.002027888,0.0001190942],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000562475,"about_ca_system_score_gemma":0.0009511712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004095241,"about_ca_topic_score_gemma":0.001805808,"domain_scores_codex":[0.9969333,0.002216564,0.000253816,0.0001365728,0.0003195191,0.0001401375],"domain_scores_gemma":[0.9972441,0.0010789,0.0009509159,0.0001998057,0.0001366306,0.0003896409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7252375,0.007624903,0.02477762,0.001336415,0.003344105,0.0001302973,0.0002619009,0.00434345,0.01204164,0.0004379044,0.003413042,0.2170512],"study_design_scores_gemma":[0.4999456,0.331193,0.1470447,0.0005429143,0.003207915,0.0004135968,0.0001357366,0.005087415,0.005574717,0.0007989214,0.005965577,0.00008990013],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864414,0.009042564,0.0003115914,0.000711764,0.0001031591,0.0006581348,0.0002775801,0.00003825404,0.002415599],"genre_scores_gemma":[0.9952863,0.001981466,0.0007915719,0.0007051866,0.0001146729,0.0004252321,0.0003257708,0.00001254069,0.0003572734],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006722196,"threshold_uncertainty_score":0.03555077,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2088123597","doi":"10.1182/blood-2004-10-3913","title":"CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":289,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; MAPK/ERK pathway; Fibroblast growth factor receptor 3; Tyrosine kinase; Receptor tyrosine kinase; Tyrosine-kinase inhibitor; Biology; Cytotoxic T cell; Kinase; Molecular biology; Fibroblast growth factor; Cell biology; Signal transduction; Receptor; In vitro; Cancer; Biochemistry","authors":[{"name":"Suzanne Trudel","is_ca":true},{"name":"Zhihua Li","is_ca":true},{"name":"Ellen Wei","is_ca":true},{"name":"Marion Wiesmann","is_ca":true},{"name":"Hong Chang","is_ca":true},{"name":"Christine Chen","is_ca":true},{"name":"Donna Reece","is_ca":true},{"name":"Carla Heise","is_ca":true},{"name":"A. Keith Stewart","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02464544621906841,"gpt":0.2835323477386202,"spread":0.2588869015195518,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007684932,0.0003557352,0.0002500103,0.0003083598,0.0001439489,0.000183112,0.0002403909,0.0002656236,0.0009154441],"category_scores_gemma":[0.00005502124,0.000104136,0.0002015081,0.0001626767,0.0001465696,0.0001312429,0.0001500554,0.0005674558,0.000318859],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000276135,"about_ca_system_score_gemma":0.0002046195,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003552515,"about_ca_topic_score_gemma":0.001153064,"domain_scores_codex":[0.9999658,0.000004892841,0.000002637643,0.0000064474,0.00001110547,0.000009142809],"domain_scores_gemma":[0.999981,0.000002920991,0.000005841245,0.000001293488,0.000002443165,0.000006465342],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007968214,0.000554366,0.0005976246,0.0003019252,0.00003084751,0.0007585944,0.00003761483,0.0009842322,0.9243807,0.0003601222,0.001672662,0.06952446],"study_design_scores_gemma":[0.001642669,0.01572729,0.01202556,0.00008170266,0.0001863239,0.006726738,0.00004726711,0.004211012,0.9152884,0.0001819914,0.04382362,0.00005741247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.960075,0.02194267,0.005101224,0.0005593664,0.0001951594,0.000371094,0.0006432333,0.0003272423,0.01078502],"genre_scores_gemma":[0.9727517,0.0137237,0.005570062,0.0002844298,0.0000871322,0.000207453,0.001260922,0.00001600825,0.006098628],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009154441,"threshold_uncertainty_score":0.003062427,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2024971109","doi":"10.1016/j.ijrobp.2005.06.039","title":"Outcomes and patterns of failure in solitary plasmacytoma: A multicenter Rare Cancer Network study of 258 patients","year":2005,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Multiple myeloma; Radiation therapy; Chemotherapy; Multivariate analysis; Cancer; Plasmacytoma; Internal medicine; Surgery; Radiology; Oncology","authors":[{"name":"Mahmut Özsahin","is_ca":false},{"name":"Richard Tsang","is_ca":true},{"name":"Philip Poortmans","is_ca":false},{"name":"Yazid Belkacémi","is_ca":false},{"name":"M. Bolla","is_ca":false},{"name":"Fazilet Öner Dinçbaş","is_ca":false},{"name":"Christine Landmann","is_ca":false},{"name":"B. Castelain","is_ca":false},{"name":"Jeroen Buijsen","is_ca":false},{"name":"Jürgen Curschmann","is_ca":false},{"name":"Sidney P. Kadish","is_ca":false},{"name":"Anna Kowalczyk","is_ca":false},{"name":"Yavuz Anacak","is_ca":false},{"name":"J. Hammer","is_ca":false},{"name":"Tan Dat Nguyen","is_ca":false},{"name":"Gabriela Studer","is_ca":false},{"name":"Rachel Cooper","is_ca":false},{"name":"Meriç Şengöz","is_ca":false},{"name":"Luciano Scandolaro","is_ca":false},{"name":"Abderrahim Zouhair","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02095780984225487,"gpt":0.3561254426836296,"spread":0.3351676328413747,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007663168,0.0004585399,0.0007549709,0.001085801,0.001167139,0.0008634009,0.0009725768,0.0006110222,0.001350946],"category_scores_gemma":[0.002472895,0.0005012273,0.0005240221,0.001796341,0.0007064316,0.001152239,0.00113967,0.0005416445,0.0002672643],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001016836,"about_ca_system_score_gemma":0.0006894229,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009881189,"about_ca_topic_score_gemma":0.01167611,"domain_scores_codex":[0.999095,0.0002437166,0.0001078488,0.0002831428,0.0001056767,0.0001645903],"domain_scores_gemma":[0.9977008,0.0003841031,0.0009873922,0.0001507893,0.0001913085,0.0005856357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001477188,0.00003825611,0.9990822,0.000003308046,0.00003530908,0.000113637,0.0001098509,0.00003888981,0.0001263345,0.000008544619,0.0000480296,0.0002479785],"study_design_scores_gemma":[0.00003237443,0.0002037227,0.9982268,0.000003509247,0.00004031801,0.0005773734,0.0005546971,0.0002071777,0.00005557971,0.0000223055,0.00006846481,0.000007781566],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9996711,0.00003798164,0.00001736154,0.00001393073,0.000001003996,0.000004196015,0.0001806957,0.000001202848,0.00007260722],"genre_scores_gemma":[0.9994004,0.00002923013,0.00002751094,0.00001431229,0.000004871363,0.000008799792,0.0004670122,0.000001724565,0.00004614435],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009881189,"threshold_uncertainty_score":0.01964736,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2172122039","doi":"10.1200/jco.2008.18.3087","title":"Single-Agent Bortezomib in Previously Untreated Multiple Myeloma: Efficacy, Characterization of Peripheral Neuropathy, and Molecular Correlations With Response and Neuropathy","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":272,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Ontario Institute for Cancer Research","funders":"National Institute of Neurological Disorders and Stroke; National Eye Institute; Takeda Oncology; Celgene","keywords":"Medicine; Bortezomib; Multiple myeloma; Polyneuropathy; Peripheral neuropathy; Internal medicine; Surgery; Oncology; Gastroenterology","authors":[{"name":"Paul G. Richardson","is_ca":true},{"name":"Wanling Xie","is_ca":true},{"name":"Constantine S. Mitsiades","is_ca":true},{"name":"Asher Chanan‐Khan","is_ca":true},{"name":"Sagar Lonial","is_ca":true},{"name":"Hani Hassoun","is_ca":true},{"name":"David Avigan","is_ca":true},{"name":"Anne Louise Oaklander","is_ca":true},{"name":"David J. Kuter","is_ca":true},{"name":"Patrick Y. Wen","is_ca":true},{"name":"Santosh Kesari","is_ca":true},{"name":"Hannah Briemberg","is_ca":true},{"name":"Robert Schlossman","is_ca":true},{"name":"Nikhil C. Munshi","is_ca":true},{"name":"Leonard T. Heffner","is_ca":true},{"name":"Deborah Doss","is_ca":true},{"name":"Dixie‐Lee Esseltine","is_ca":true},{"name":"Edie Weller","is_ca":true},{"name":"Kenneth C. Anderson","is_ca":true},{"name":"Anthony A. Amato","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05753808831090486,"gpt":0.3811943247090732,"spread":0.3236562363981684,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006030297,0.0002874169,0.000776243,0.0003218465,0.0001952673,0.0001853607,0.00018994,0.0002479905,0.0005589326],"category_scores_gemma":[0.0007314748,0.0001080359,0.0002317377,0.0002840222,0.000223505,0.0002081622,0.0001411829,0.0002575601,0.0001119007],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004532484,"about_ca_system_score_gemma":0.0002238375,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006324755,"about_ca_topic_score_gemma":0.001779003,"domain_scores_codex":[0.9997373,0.00008377832,0.00002655717,0.00005861478,0.00006122535,0.00003243264],"domain_scores_gemma":[0.9995956,0.0001114608,0.0001445003,0.00001926461,0.00003026254,0.00009888763],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.02693871,0.001531423,0.7108043,0.0006154394,0.0006484793,0.0009819506,0.000278348,0.002653934,0.1195208,0.00006282883,0.0004127884,0.1355509],"study_design_scores_gemma":[0.001489025,0.0341154,0.9415469,0.00004682165,0.000306659,0.003625287,0.0001125537,0.002539643,0.01504953,0.000109881,0.001040143,0.00001799975],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976545,0.002012449,0.00009730689,0.000025049,0.000003657501,0.00001861351,0.00004825266,0.000006639909,0.0001335308],"genre_scores_gemma":[0.9990693,0.0003865213,0.0002473408,0.0000385052,0.00001295263,0.00001769715,0.0001347815,0.000001545331,0.00009150643],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000776243,"threshold_uncertainty_score":0.003288567,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2769593282","doi":"10.1182/blood-2017-07-795047","title":"Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":271,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; University of Calgary","funders":"National Cancer Institute; Celgene","keywords":"Multiple myeloma; Medicine; Internal medicine; Oncology; Progression-free survival; Overall survival; Surgery","authors":[{"name":"Thierry Façon","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Angela Dispenzieri","is_ca":false},{"name":"John Catalano","is_ca":false},{"name":"Andrew Belch","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Katja Weisel","is_ca":false},{"name":"Heinz Ludwig","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Anne Banos","is_ca":false},{"name":"Mourad Tiab","is_ca":false},{"name":"Michel Delforge","is_ca":false},{"name":"Jamie Cavenagh","is_ca":false},{"name":"Catarina Geraldes","is_ca":false},{"name":"Je‐Jung Lee","is_ca":false},{"name":"Christine Chen","is_ca":true},{"name":"Albert Oriol","is_ca":false},{"name":"Javier de la Rubia","is_ca":false},{"name":"Darrell White","is_ca":true},{"name":"Daniel Binder","is_ca":false},{"name":"Jin Lu","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false},{"name":"Philippe Moreau","is_ca":false},{"name":"Michel Attal","is_ca":false},{"name":"Aurore Perrot","is_ca":false},{"name":"Bertrand Arnulf","is_ca":false},{"name":"Lugui Qiu","is_ca":false},{"name":"Murielle Roussel","is_ca":false},{"name":"Eileen M. Boyle","is_ca":false},{"name":"Salomon Manier","is_ca":false},{"name":"Mohamad Mohty","is_ca":false},{"name":"Hervé Avet‐Loiseau","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Annette Ervin‐Haynes","is_ca":false},{"name":"Guang Chen","is_ca":false},{"name":"Vanessa Houck","is_ca":false},{"name":"Lotfi Benboubker","is_ca":false},{"name":"Cyrille Hulin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1205824684812269,"gpt":0.4038414628693454,"spread":0.2832589943881185,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005327185,0.000730161,0.001449058,0.0003366792,0.000298283,0.00100099,0.0007410722,0.0006748945,0.0103288],"category_scores_gemma":[0.003483189,0.0002243246,0.003998449,0.000393167,0.000423278,0.0006889763,0.0006126279,0.002060877,0.0009407848],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007260864,"about_ca_system_score_gemma":0.001608051,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009344504,"about_ca_topic_score_gemma":0.002612629,"domain_scores_codex":[0.9981976,0.001210474,0.00006556322,0.0001848778,0.0001311516,0.0002103567],"domain_scores_gemma":[0.9972785,0.0007693948,0.0007059582,0.0004784613,0.0001828407,0.0005848613],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8907987,0.004646129,0.01450177,0.0009650899,0.008278574,0.0001815995,0.00008722628,0.002957104,0.0052465,0.0004203902,0.02156583,0.05035105],"study_design_scores_gemma":[0.5996208,0.2153613,0.135666,0.0003224515,0.01109591,0.0007519157,0.0001201318,0.004168968,0.005096362,0.00151113,0.02620101,0.00008408538],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9408494,0.007020957,0.002278948,0.001530067,0.0003651746,0.003922066,0.03343876,0.0002641396,0.01033045],"genre_scores_gemma":[0.9529777,0.001034912,0.003297205,0.001017325,0.0002299675,0.002811505,0.03041052,0.00009366295,0.008127198],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0103288,"threshold_uncertainty_score":0.03455329,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3134103265","doi":"10.1016/s1470-2045(20)30756-7","title":"Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group","year":2021,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":268,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary; Hotel Dieu Hospital","funders":"Janssen Pharmaceuticals; Merck Sharp and Dohme; Genesis Pharma; Genentech; National Natural Science Foundation of China; Takeda Pharmaceutical Company; AbbVie; Sanofi; Roche; Novartis; GlaxoSmithKline; Celgene; Bayer; Bristol-Myers Squibb; AstraZeneca; Amgen; Pfizer","keywords":"Multiple myeloma; Refractory (planetary science); Medicine; Clinical trial; Internal medicine; Oncology; Clinical Practice; Family medicine","authors":[{"name":"Philippe Moreau","is_ca":true},{"name":"Shaji Kumar","is_ca":false},{"name":"Jesús F. San Miguel","is_ca":false},{"name":"Faith E. Davies","is_ca":false},{"name":"Elena Zamagni","is_ca":false},{"name":"Nizar J. Bahlis","is_ca":true},{"name":"Heinz Ludwig","is_ca":false},{"name":"Joseph Mıkhael","is_ca":false},{"name":"Evangelos Terpos","is_ca":false},{"name":"Fredrik Schjesvold","is_ca":false},{"name":"Thomas G. Martin","is_ca":false},{"name":"Kwee Yong","is_ca":false},{"name":"Brian G.M. Durie","is_ca":false},{"name":"Thierry Façon","is_ca":false},{"name":"Artur Jurczyszyn","is_ca":false},{"name":"Surbhi Sidana","is_ca":false},{"name":"Noopur Raje","is_ca":false},{"name":"Niels W.C.J. van de Donk","is_ca":false},{"name":"Sagar Lonial","is_ca":false},{"name":"Michèle Cavo","is_ca":false},{"name":"Sigurður Y. Kristinsson","is_ca":false},{"name":"Suzanne Lentzsch","is_ca":false},{"name":"Roman Hájek","is_ca":false},{"name":"Kenneth C. Anderson","is_ca":false},{"name":"Cristina João","is_ca":false},{"name":"Hermann Einsele","is_ca":false},{"name":"Pieter Sonneveld","is_ca":false},{"name":"Monika Engelhardt","is_ca":false},{"name":"Rafaël Fonseca","is_ca":false},{"name":"Annette Juul Vangsted","is_ca":false},{"name":"Katja Weisel","is_ca":false},{"name":"Rachid Baz","is_ca":false},{"name":"Vânia Hungria","is_ca":false},{"name":"Jesús G. Berdeja","is_ca":false},{"name":"Fernando Leal da Costa","is_ca":false},{"name":"Ângelo Maiolino","is_ca":false},{"name":"Anders Waage","is_ca":false},{"name":"David H. Vesole","is_ca":false},{"name":"Enrique M. Ocio","is_ca":false},{"name":"Hang Quach","is_ca":false},{"name":"Christoph Driessen","is_ca":false},{"name":"Joan Bladé","is_ca":false},{"name":"Xavier Leleu","is_ca":false},{"name":"Eloísa Riva","is_ca":false},{"name":"P. Leif Bergsagel","is_ca":false},{"name":"Jian Hou","is_ca":false},{"name":"Wee Joo Chng","is_ca":false},{"name":"Ulf‐Henrik Mellqvist","is_ca":false},{"name":"Dominik Dytfeld","is_ca":false},{"name":"Jean‐Luc Harousseau","is_ca":false},{"name":"Hartmut Goldschmidt","is_ca":false},{"name":"Jacob P. Laubach","is_ca":false},{"name":"Nikhil C. Munshi","is_ca":false},{"name":"Francesca Gay","is_ca":false},{"name":"Meral Beksaç","is_ca":false},{"name":"Luciano J. Costa","is_ca":false},{"name":"Martin Kaiser","is_ca":false},{"name":"Parameswaran Hari","is_ca":false},{"name":"Mario Boccadoro","is_ca":false},{"name":"Saad Z. Usmani","is_ca":false},{"name":"Sonja Zweegman","is_ca":false},{"name":"Sarah A. Holstein","is_ca":false},{"name":"Orhan Sezer","is_ca":false},{"name":"Simon J. Harrison","is_ca":false},{"name":"Hareth Nahi","is_ca":false},{"name":"Gordon Cook","is_ca":false},{"name":"María‐Victoria Mateos","is_ca":false},{"name":"S. Vincent Rajkumar","is_ca":false},{"name":"Meletios Α. Dimopoulos","is_ca":false},{"name":"Paul G. Richardson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1789959106822273,"gpt":0.4230512628501331,"spread":0.2440553521679057,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005317153,0.001515419,0.004267758,0.004064594,0.0004424506,0.002655464,0.002809253,0.004085834,0.005372482],"category_scores_gemma":[0.005816826,0.0006025508,0.003492223,0.003671412,0.0007965606,0.002365696,0.001627673,0.006325037,0.002841794],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003448633,"about_ca_system_score_gemma":0.009274736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009503485,"about_ca_topic_score_gemma":0.01862157,"domain_scores_codex":[0.9986514,0.0003472947,0.000345163,0.0001521195,0.0003943393,0.0001097986],"domain_scores_gemma":[0.9966487,0.001452524,0.0006869585,0.00005002143,0.0009106778,0.0002511172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000499453,0.0001294606,0.0002356305,0.06137076,0.0006929333,0.0001129079,0.00007948722,0.0005395732,0.0005545349,0.00399293,0.2666247,0.6651676],"study_design_scores_gemma":[0.0005369191,0.000187675,0.001137797,0.06800064,0.001648676,0.0002290816,0.00008507992,0.0001540653,0.0001580097,0.003236759,0.9245782,0.00004711999],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003316838,0.9915898,0.0001141529,0.005794284,0.00174101,0.0000357488,0.0001627301,0.00001382179,0.0005153501],"genre_scores_gemma":[0.00031754,0.9921992,0.0005852677,0.005494996,0.0007064915,0.00006387414,0.0001716716,0.000004930248,0.0004560461],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009503485,"threshold_uncertainty_score":0.0281201,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}